# EDGAR Filing Document

**Accession Number:** 0000008177
**File Stem:** 0001140361-25-042275
**Filing Date:** 2025-11
**Character Count:** 136554
**Document Hash:** 6401daf0f55ce04263da00a8560e1843
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001140361-25-042275.hdr.sgml**: 20251114

**ACCESSION NUMBER**: 0001140361-25-042275

**CONFORMED SUBMISSION TYPE**: 10-Q

**PUBLIC DOCUMENT COUNT**: 77

**CONFORMED PERIOD OF REPORT**: 20250930

**FILED AS OF DATE**: 20251114

**DATE AS OF CHANGE**: 20251114

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ATLANTIC AMERICAN CORP
- **CENTRAL INDEX KEY:** 0000008177
- **STANDARD INDUSTRIAL CLASSIFICATION:** LIFE INSURANCE [6311]
- **ORGANIZATION NAME:** 02 Finance
- **EIN:** 581027114
- **STATE OF INCORPORATION:** GA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 10-Q
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 000-03722
- **FILM NUMBER:** 251485023

**BUSINESS ADDRESS:**
- **STREET 1:** 4370 PEACHTREE RD NE
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30319
- **BUSINESS PHONE:** 4042665500

**MAIL ADDRESS:**
- **STREET 1:** 4370 PEACHTREE ROAD
- **CITY:** ATLANTA
- **STATE:** GA
- **ZIP:** 30319

?xml version='1.0' encoding='ASCII'?

------

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

### FORM 10-Q
☑ QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2025

or

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 0-3722

## ATLANTIC AMERICAN CORPORATION
(*Exact name of registrant as specified in its charter)*

---

| | |
|:---|:---|
| **Georgia** | **58-1027114** |
| *(State or other jurisdiction of incorporation or organization)* | *(I.R.S. Employer Identification No.)* |

---

---

| | |
|:---|:---|
| **4370 Peachtree Road, N.E.,**<br> **Atlanta, Georgia** | **30319** |
| *(Address of principal executive offices)* | *(Zip Code)* |

---

(404) 266-5500

*(Registrant's telephone number, including area code)*

Securities registered pursuant to Section 12(b) of the Act:

---

| | |
|:---|:---|
| **Title of each class** | **Name of each exchange on which registered** |
| Common Stock, par value $1.00 per share<br> AAME | NASDAQ Global Market |

---

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company," and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated filer ☑ Smaller reporting company ☑ Emerging growth company ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☑

The total number of shares of the registrant's Common Stock, $1 par value, outstanding on October 31, 2025 was 20,397,228**.**

------

#### **TABLE OF CONTENTS**

---

| | | |
|:---|:---|:---|
|  | [Forward-Looking Statements](#FORWARD-LOOKINGSTATEMENTS) | 2 |
| Part I. | **Financial Information** |  |
| Item 1. | [Financial Statements:](#FinancialStatements) | 3 |
|  | [Condensed Consolidated Balance Sheets as of September 30, 2025 (unaudited) and December 31, 2024](#BALANCESHEETS) | 3 |
|  | [Condensed Consolidated Statements of Operations for the three months and nine months ended September 30, 2025 and 2024 (unaudited)](#STATEMENTSOFOPERATIONS) | 4 |
|  | [Condensed Consolidated Statements of Comprehensive Income (Loss) for the three months and nine months ended September 30, 2025 and 2024 (unaudited)](#COMPREHENSIVEINCOMELOSS) | 5 |
|  | [Condensed Consolidated Statements of Shareholders' Equity for the three months and nine months ended September 30, 2025 and 2024 (unaudited)](#SHAREHOLDERSEQUITY) | 6 |
|  | [Condensed Consolidated Statements of Cash Flows for the nine months ended September 30, 2025 and 2024 (unaudited)](#CASHFLOWS) | 7 |
|  | [Notes to Unaudited Condensed Consolidated Financial Statements](#NOTESTOUNAUDITEDCONDENSED) | 8 |
| Item 2. | [Management's Discussion and Analysis of Financial Condition and Results of Operations](#Item2.) | 22 |
| Item 4. | [Controls and Procedures](#Item4.ControlsandProcedur) | 28 |
| **Part II.** | **Other Information** |  |
| Item 2. | [Unregistered Sales of Equity Securities and Use of Proceeds](#Item2.UnregisteredSalesof) | 30 |
| Item 5. | [Other Information](#Item5.OtherInformation) | 30 |
| Item 6. | [Exhibits](#Item6.Exhibits) | 30 |
| [<u>Signatures</u>](#SIGNATURES) | [<u>Signatures</u>](#SIGNATURES) | 31 |

---

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

#### FORWARD-LOOKING STATEMENTS
Certain of the statements contained herein are forward-looking statements within the meaning of the federal securities laws. Forward-looking statements are all statements other than those of historical fact. These forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, and include estimates and assumptions related to, among other things, general economic, competitive, operational and legislative developments, expectations and trends. Forward-looking statements are inherently subject to risks and uncertainties which are, in many instances, beyond the Company's control and have been made based upon management's current expectations and beliefs concerning future developments and their potential effect upon the Company. There can be no assurance that future developments will be in accordance with management's expectations or that the effect of future developments on the Company will be those anticipated by management. Actual results could differ materially from those expressed by forward-looking statements, depending on the occurrence or outcome of various factors. These factors include, among others: the effects of macroeconomic conditions and general economic uncertainty; unexpected developments in the health care or insurance industries affecting providers or individuals, including the cost or availability of services, or the tax consequences related thereto; disruption to the financial markets; unanticipated increases in the rate, number and amounts of claims outstanding; the level of performance of reinsurance companies under reinsurance contracts and the availability, pricing and adequacy of reinsurance to protect the Company against losses; changes in the stock markets, interest rates or other financial markets, including the potential effect on the Company's statutory capital levels; the uncertain effect on the Company of regulatory and market-driven changes in practices relating to the payment of incentive compensation to brokers, agents and other producers; the potential impact of public health emergencies; the incidence and severity of catastrophes, both natural and man-made; the possible occurrence of terrorist attacks; stronger than anticipated competitive activity; unfavorable judicial or legislative developments; the potential effect of regulatory developments, including those which could increase the Company's business costs and required capital levels; the Company's ability to distribute its products through distribution channels, both current and future; the uncertain effect of emerging claim and coverage issues; the effect of assessments and other surcharges for guaranty funds and other mandatory pooling arrangements; information technology system failures or network disruptions; and risks related to cybersecurity matters, such as breaches of our computer network or those of other parties or the loss of or unauthorized access to the data we maintain. As a result, undue reliance should not be placed upon forward-looking statements, which speak only as of the date they are made. The Company undertakes no obligation to publicly update any forward-looking statements as a result of subsequent developments, changes in underlying assumptions or facts or otherwise, except as may be required by law.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

#### PART I. FINANCIAL INFORMATION
<u>Item 1. Financial Statements</u>

#### ATLANTIC AMERICAN CORPORATION

#### CONDENSED CONSOLIDATED BALANCE SHEETS
*(In thousands, except share and per share data)*

---

| | | |
|:---|:---|:---|
|  | *Unaudited*<br> September 30,<br> 2025 | December 31,<br> 2024 |
|  **ASSETS** |  |  |
|  Cash and cash equivalents | $34444 | $35570 |
|  Investments: |  |  |
| &nbsp;&nbsp;&nbsp; Fixed maturities, available-for-sale, at fair value (amortized cost: $251,703 and $236,299; no allowance for credit losses) | 235469 | 212612 |
| &nbsp;&nbsp;&nbsp; Equity securities, at fair value (cost: $4,943 and $4,939) | 10432 | 7900 |
| &nbsp;&nbsp;&nbsp; Other invested assets (cost: $7,946 and $7,946) | 6225 | 6616 |
| &nbsp;&nbsp;&nbsp; Policy loans | 1668 | 1722 |
| &nbsp;&nbsp;&nbsp; Real estate | 38 | 38 |
| &nbsp;&nbsp;&nbsp; Investment in unconsolidated trusts | 1238 | 1238 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total investments | 255070 | 230126 |
|  Receivables: |  |  |
| &nbsp;&nbsp;&nbsp; Reinsurance (net of allowance for expected credit losses of $43 and $51) | 22694 | 22942 |
| &nbsp;&nbsp;&nbsp; Insurance premiums and other (net of allowance for expected credit losses of $209 and $201) | 42399 | 27458 |
|  Deferred income taxes, net | 16089 | 18118 |
|  Deferred acquisition costs | 45759 | 44842 |
|  Other assets | 11856 | 11828 |
|  Intangibles | 2544 | 2544 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total assets | $430855 | $393428 |
|  **LIABILITIES AND SHAREHOLDERS' EQUITY** |  |  |
|  Insurance reserves and policyholder funds: |  |  |
| &nbsp;&nbsp;&nbsp; Future policy benefits | $103159 | $98464 |
| &nbsp;&nbsp;&nbsp; Unearned premiums | 36869 | 31178 |
| &nbsp;&nbsp;&nbsp; Losses and claims | 107713 | 93707 |
| &nbsp;&nbsp;&nbsp; Other policy liabilities | 1837 | 1757 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total insurance reserves and policyholder funds | 249578 | 225106 |
|  Accounts payable and accrued expenses | 34030 | 30948 |
|  Revolving credit facility | 4021 | 4023 |
|  Junior subordinated debenture obligations, net | 33738 | 33738 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities | 321367 | 293815 |
|  Commitments and contingencies (Notes 3 and 12) |  |  |
|  Shareholders' equity: |  |  |
| &nbsp;&nbsp;&nbsp; Preferred stock, $1 par, 4,000,000 shares authorized; Series D preferred, 55,000 shares issued and outstanding; $5,500 redemption value | 55 | 55 |
| &nbsp;&nbsp;&nbsp; Common stock, $1 par, 50,000,000 shares authorized; shares issued: 22,400,894; shares outstanding: 20,397,228 and 20,399,758 | 22401 | 22401 |
| &nbsp;&nbsp;&nbsp; Additional paid-in capital | 57425 | 57425 |
| &nbsp;&nbsp;&nbsp; Retained earnings | 49843 | 45854 |
| &nbsp;&nbsp;&nbsp; Accumulated other comprehensive loss | (12824) | (18712) |
| &nbsp;&nbsp;&nbsp; Unearned stock grant compensation |  | (2) |
| &nbsp;&nbsp;&nbsp; Treasury stock, at cost: 2,003,666 and 2,001,136 shares | (7412) | (7408) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total shareholders' equity | 109488 | 99613 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total liabilities and shareholders' equity | $430855 | $393428 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

#### ATLANTIC AMERICAN CORPORATION

#### CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
*(Unaudited; Dollars in thousands, except per share data)*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
|  Revenue: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Insurance premiums, net | $51972 | $43782 | $149031 | $133327 |
| &nbsp;&nbsp;&nbsp; Net investment income | 2633 | 2477 | 7591 | 7449 |
| &nbsp;&nbsp;&nbsp; Realized investment gains, net | 2 | 4 | 18 | 17 |
| &nbsp;&nbsp;&nbsp; Unrealized gains (losses) on equity securities, net | (848) | (1746) | 2528 | (1617) |
| &nbsp;&nbsp;&nbsp; Other income | 1 | 2 | 7 | 8 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total revenue | 53760 | 44519 | 159175 | 139184 |
|  Benefits and expenses: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Insurance benefits and losses incurred | 35471 | 30760 | 101031 | 94492 |
| &nbsp;&nbsp;&nbsp; Commissions and underwriting expenses | 12955 | 11490 | 37505 | 35740 |
| &nbsp;&nbsp;&nbsp; Interest expense | 779 | 869 | 2326 | 2591 |
| &nbsp;&nbsp;&nbsp; Other expense | 3786 | 3854 | 12293 | 12170 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total benefits and expenses | 52991 | 46973 | 153155 | 144993 |
|  Income (loss) before income taxes | 769 | (2454) | 6020 | (5809) |
|  Income tax expense (benefit) | 192 | (456) | 1325 | (1129) |
|  Net income (loss) | 577 | (1998) | 4695 | (4680) |
|  Preferred stock dividends | (100) | (100) | (299) | (299) |
|  Net income (loss) applicable to common shareholders | $477 | $(2098) | $4396 | $(4979) |
|  Earnings (loss) per common share (basic) | $.02 | $(.10) | $.22 | $(.24) |
|  Earnings (loss) per common share (diluted) | $.02 | $(.10) | $.22 | $(.24) |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

#### ATLANTIC AMERICAN CORPORATION

#### CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
*(Unaudited; Dollars in thousands)*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
|  Net income (loss) | $577 | $(1998) | $4695 | $(4680) |
|  Other comprehensive income: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Available-for-sale fixed maturity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Gross unrealized holding gains arising in the period | 3601 | 9095 | 7471 | 4913 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Related income tax effect | (757) | (1910) | (1569) | (1032) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Subtotal | 2844 | 7185 | 5902 | 3881 |
| &nbsp;&nbsp;&nbsp; Less: reclassification adjustment for net realized gains included in net income (loss) | (2) | (4) | (18) | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Related income tax effect | 1 | 1 | 4 | 4 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Subtotal | (1) | (3) | (14) | (13) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total other comprehensive income, net of tax | 2843 | 7182 | 5888 | 3868 |
|  Total comprehensive income (loss) | $3420 | $5184 | $10583 | $(812) |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

#### ATLANTIC AMERICAN CORPORATION

#### CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY
*(Unaudited; Dollars in thousands except share data)*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
|  **Preferred stock:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Balance, beginning of period | $55 | $55 | $55 | $55 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Balance, end of period | 55 | 55 | 55 | 55 |
|  **Common stock:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Balance, beginning of period | 22401 | 22401 | 22401 | 22401 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Balance, end of period | 22401 | 22401 | 22401 | 22401 |
|  **Additional paid-in capital:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Balance, beginning of period | 57425 | 57425 | 57425 | 57425 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Balance, end of period | 57425 | 57425 | 57425 | 57425 |
|  **Retained earnings:** |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Balance, beginning of period | 49366 | 47641 | 45854 | 50929 |
| &nbsp;&nbsp;&nbsp; Net income (loss) | 577 | (1998) | 4695 | (4680) |
| &nbsp;&nbsp;&nbsp; Dividends on common stock |  |  | (407) | (407) |
| &nbsp;&nbsp;&nbsp; Dividends accrued on preferred stock | (100) | (100) | (299) | (299) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Balance, end of period | 49843 | 45543 | 49843 | 45543 |
|  **Accumulated other comprehensive loss:**  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Balance, beginning of period | (15667) | (19435) | (18712) | (16121) |
| &nbsp;&nbsp;&nbsp; Other comprehensive income, net of tax | 2843 | 7182 | 5888 | 3868 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Balance, end of period | (12824) | (12253) | (12824) | (12253) |
|  **Unearned stock grant compensation:**  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Balance, beginning of period |  | (7) | (2) | (13) |
| &nbsp;&nbsp;&nbsp; Amortization of unearned compensation |  | 3 | 2 | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Balance, end of period |  | (4) |  | (4) |
|  **Treasury stock:**  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Balance, beginning of period | (7412) | (7408) | (7408) | (7401) |
| &nbsp;&nbsp;&nbsp; Net shares acquired related to employee share-based compensation plans |  |  | (4) | (7) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Balance, end of period | (7412) | (7408) | (7412) | (7408) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; **Total shareholders' equity**  | $109488 | $105759 | $109488 | $105759 |
|  **Dividends declared on common stock per share**  | $— | $— | $.02 | $.02 |
|  **Common shares outstanding:**  |  |  |  |  |
|  Balance, beginning of period | 20397228 | 20399758 | 20399758 | 20402288 |
|  Net shares acquired under employee share-based compensation plans |  |  | (2530) | (2530) |
|  Balance, end of period | 20397228 | 20399758 | 20397228 | 20399758 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

#### ATLANTIC AMERICAN CORPORATION

#### CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
*(Unaudited; In thousands)*

---

| | | |
|:---|:---|:---|
|  | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 |
|  **CASH FLOWS FROM OPERATING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp; Net income (loss) | $4695 | $(4680) |
| &nbsp;&nbsp;&nbsp; Adjustments to reconcile net income (loss) to net cash provided (used) in operating activities: |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Capitalization of acquisition costs, net | (917) | (434) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Realized investment gains, net | (18) | (17) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Unrealized (gains) losses on equity securities | (2528) | 1617 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Losses from equity method investees | 391 | 494 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Compensation expense related to share awards | 2 | 9 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Benefit for credit losses |  | (10) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Depreciation and amortization | 277 | 297 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Deferred income tax expense (benefit) | 464 | (1425) |
| &nbsp;&nbsp;&nbsp; Increase in receivables, net | (14693) | (7289) |
| &nbsp;&nbsp;&nbsp; Increase in insurance reserves and policyholder funds | 24472 | 6460 |
| &nbsp;&nbsp;&nbsp; Increase (decrease) in accounts payable and accrued expenses | 2783 | (524) |
| &nbsp;&nbsp;&nbsp; Other, net | 270 | 689 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash provided by (used in) operating activities | 15198 | (4813) |
|  **CASH FLOWS FROM INVESTING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp; Proceeds from investments sold | 13447 | 40 |
| &nbsp;&nbsp;&nbsp; Proceeds from investments matured, called or redeemed | 13406 | 9963 |
| &nbsp;&nbsp;&nbsp; Investments purchased | (42301) | (10916) |
| &nbsp;&nbsp;&nbsp; Additions to property and equipment | (465) | (126) |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash used in investing activities | (15913) | (1039) |
|  **CASH FLOWS FROM FINANCING ACTIVITIES:** |  |  |
| &nbsp;&nbsp;&nbsp; Payment of dividends on common stock | (407) | (407) |
| &nbsp;&nbsp;&nbsp; Treasury stock acquired — net employee share-based compensation | (4) | (7) |
| &nbsp;&nbsp;&nbsp; Proceeds from revolving credit facility, net |  | 1000 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Net cash (used in) provided by financing activities | (411) | 586 |
|  Net decrease in cash and cash equivalents | (1126) | (5266) |
|  Cash and cash equivalents at beginning of period | 35570 | 28301 |
|  Cash and cash equivalents at end of period | $34444 | $23035 |
|  **SUPPLEMENTAL CASH FLOW INFORMATION:** |  |  |
|  Cash paid for interest | $2342 | $2600 |
|  Cash paid for income taxes | $952 | $580 |

---

The accompanying notes are an integral part of these condensed consolidated financial statements.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

#### ATLANTIC AMERICAN CORPORATION

#### NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
*(Dollars in thousands, except per share amounts)*

---

| | |
|:---|:---|
| **<u>Note 1.</u>** | Basis of Presentation and Significant Accounting Policies |

---

The accompanying unaudited condensed consolidated financial statements include the accounts of Atlantic American Corporation (the "Parent") and its subsidiaries (collectively with the Parent, the "Company"). The Parent's primary operating subsidiaries, American Southern Insurance Company and American Safety Insurance Company (together known as "American Southern") and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (together known as "Bankers Fidelity"), operate in two principal business units. American Southern operates in the property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. All significant intercompany accounts and transactions have been eliminated in consolidation. The accompanying financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("GAAP") for interim financial information and with the instructions to Form 10-Q and Article 8 of Regulation S-X. Accordingly, they do not include all of the information and notes required by GAAP for audited annual financial statements. In the opinion of management, all adjustments (consisting only of normal recurring adjustments) considered necessary for a fair presentation have been included. The unaudited condensed consolidated financial statements included herein and these related notes should be read in conjunction with the Company's consolidated financial statements, and the notes thereto, included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 (the "2024 Annual Report"). For more information regarding Significant Accounting Policies, see the "Summary of Significant Accounting Policies" section of Note 1 of Notes to Consolidated Financial Statements in the 2024 Annual Report. The Company's financial condition and operating results as of and for the three month and nine month periods ended September 30, 2025 are not necessarily indicative of the financial condition or results of operations and cash flows that may be expected for the year ending December 31, 2025 or for any other future period.

The preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported amount of assets and liabilities, disclosures of contingent assets and liabilities at the date of the financial statements, and the reported amounts of revenues and expenses during the reporting period. Actual results could differ materially from those estimates. To the extent that the Company changes its accounting for, or presentation of, items in the financial statements, the presentation of such amounts in prior periods is changed to conform to the current period presentation, if appropriate, and disclosed, if material.

#### Enactment of the One Big Beautiful Bill Act of 2025
On July 4, 2025, the U.S. enacted a budget reconciliation package known as the One Big Beautiful Bill Act of 2025 ("OBBBA") which includes both tax and non-tax provisions. The OBBBA includes significant provisions, such as the permanent extension of certain expiring provisions of the Tax Cuts and Jobs Act, modifications to the international tax framework and the restoration of favorable tax treatment for certain business provisions. The legislation has multiple effective dates, with certain provisions effective in 2025 and others to be implemented through 2027. Management does not believe this legislation will have a material impact on the Company's consolidated financial statements.

---

| | |
|:---|:---|
| **<u>Note 2</u>.** | Recently Issued Accounting Standards |

---

#### Future Adoption of New Accounting Standards
**Accounting for Long-Duration Contracts.** In August 2018, the FASB issued ASU No. 2018-12, Financial Services —Insurance (Topic 944): Targeted Improvements to the Accounting for Long-Duration Contracts ("ASU 2018-12"). This guidance (1) improves the timeliness of recognizing changes in the liability for future policy benefits and modifies the rate used to discount future cash flows, by updating the assumptions used in measuring the liability for future policy benefits for these contracts at least annually rather than establishing them at contract inception and retaining them over the life of the contracts, which will improve the timeliness of recognizing changes in the liability that are caused by deviations in experience from the assumptions, and these deviations will be recognized and reflected in the liability for future benefits as they occur, (2) improves the accounting for certain market-based options or guarantees associated with deposit (or account balance) contracts, (3) simplifies the amortization of deferred acquisition costs; amortization on a constant level basis will be used in place of a complex actuarial methodology that is in place under existing financial reporting standards, and (4) improves the effectiveness of the required disclosures, with additional disclosures required, including disaggregated rollforwards of deferred acquisition costs, liabilities for future policy benefits, market risk benefits and liability for policyholders' account balances. ASU 2018-12 is effective for annual reporting periods beginning after December 15, 2024 and interim periods beginning after December 15, 2025, although earlier adoption is permitted.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

The Company has completed the development of the necessary actuarial models that will be used to estimate both the liability for future benefits and the amortization of deferred acquisition costs for the affected policies and is in the process of testing the models to ensure that they reflect all applicable assumptions and product parameters. This testing includes an evaluation of the components of the amounts that will be disclosed for the transition liability under ASU 2018-12 in the Company's consolidated financial statements as of and for the year ending December 31, 2025. The Company expects its life, Medicare supplement and certain individual accident and health products to fall within the scope of this standard. The Company has selected the modified retrospective transition method, which requires the guidance to be applied as of the beginning of the earliest period presented on the financial statements, beginning on January 1, 2024 ("Transition Date"). The modified retrospective transition method generally results in applying the standard to contracts on the basis of existing carrying value as of the Transition Date. On the Transition Date, the Company calculates the ratio of expected benefits less existing carrying values to gross premiums (net premium ratio) using updated assumptions and the discount rate immediately before the Transition Date. The Company uses the net premium ratio calculated on the Transition Date (and capped at 100% if required) to calculate the liability for future policy benefits. Upon adoption, opening equity will be adjusted for the Transaction Date impacts to accumulated other comprehensive income and retained earnings and prior periods presented (2024) will be restated following ASU 2018-12. The disclosures under ASU 2018-12 will change significantly, and the impact on our consolidated financial statements is expected to be material.

**Internal Use Software.** In September 2025, the FASB issued ASU No. 2025-06, Targeted Improvements to the Accounting for Internal-Use Software- Intangibles—Goodwill and Other— Internal-Use Software (Subtopic 350-40) ("ASU 2025-06"). This ASU was issued to improve the accounting for internal-use software under ASC 350-40. The update addresses limitations in prior guidance that did not reflect contemporary software development practices. The amendments apply to all entities that develop or acquire software for internal use and are intended to improve consistency in capitalization decisions, reduce complexity, and align accounting with real-world development processes.

Under the amendments introduced by ASU 2025-06 to ASC 350-40, entities are required to capitalize internal use software costs only when both of the following conditions are met:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. Management Authorization: Management has authorized and committed to funding the software project.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. Probable-to-Complete Threshold: It is probable that the project will be completed, and the software will be used to perform its intended function.

In evaluating the probable-to-complete recognition threshold, an entity is required to consider whether there is significant uncertainty associated with the development activities of the software (referred to as "significant development uncertainty"). The two factors to consider in determining whether there is significant development uncertainty are whether:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1. The software being developed has technological innovations or novel, unique, or unproven functions or features, and the uncertainty related to those technological innovations, functions, or features, if identified, has not been resolved
 through coding and testing.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2. The entity has determined what it needs the software to do (for example, functions or features), including whether the entity has identified or continues to substantially revise the software's significant performance requirements.

If significant development uncertainty exists, capitalization should be deferred until the uncertainty is resolved. This principles-based threshold replaces the prior reliance on development stages and introduces a more consistent and judgment-based recognition model. This clarification ensures that costs are capitalized only when the project is sufficiently stable and likely to deliver its intended functionality. The ASU is effective for public business entities for annual reporting periods beginning after December 15, 2027, and interim periods within those annual periods. Early adoption is permitted as of the beginning of an annual reporting period. Lastly, entities may choose to adopt prospectively, modified retrospectively or full retrospectively. The Company is evaluating the new guidance and any effect it will have on the Company's consolidated financial statements.

For more information regarding accounting standards that the Company has not yet adopted, see the "Recently Issued Accounting Standards - Future Adoption of New Accounting Standards" section of Note 1 of Notes to Consolidated Financial Statements in the 2024 Annual Report.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

---

| | |
|:---|:---|
| **<u>Note 3.</u>** | Investments |

---

The following tables set forth the estimated fair value, gross unrealized gains, gross unrealized losses, allowance for credit losses and cost or amortized cost of the Company's investments in fixed maturities and equity securities, aggregated by type and industry, as of September 30, 2025 and December 31, 2024.

Fixed maturities were comprised of the following:

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | September 30, 2025 | September 30, 2025 | September 30, 2025 | September 30, 2025 | September 30, 2025 |
|  | Estimated<br> Fair Value | Gross<br> Unrealized<br> Gains | Gross<br> Unrealized<br> Losses | Allowance for<br> Credit Losses | Cost or<br> Amortized<br> Cost |
|  Fixed maturities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Bonds: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; U.S. Treasury securities and obligations of U.S. Government agencies and authorities | $23952 | $172 | $1609 | $— | $25389 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loan backed and structured securities | 28737 | 176 | 2045 |  | 30606 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Obligations of states and political subdivisions | 7393 | 16 | 1389 |  | 8766 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate securities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Utilities and telecom | 30162 | 312 | 2539 |  | 32389 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial services | 62866 | 1036 | 3129 |  | 64959 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other business – diversified | 38158 | 219 | 3060 |  | 40999 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other consumer – diversified | 43997 | 106 | 4511 |  | 48402 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total corporate securities | 175183 | 1673 | 13239 |  | 186749 |
| &nbsp;&nbsp;&nbsp; Redeemable preferred stocks: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other consumer – diversified | 204 | 11 |  |  | 193 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total redeemable preferred stocks | 204 | 11 |  |  | 193 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total fixed maturities | $235469 | $2048 | $18282 | $— | $251703 |

---

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | December 31, 2024 | December 31, 2024 | December 31, 2024 | December 31, 2024 | December 31, 2024 |
|  | Estimated<br> Fair Value | Gross<br> Unrealized<br> Gains | Gross<br> Unrealized<br> Losses | Allowance for<br> Credit Losses | Cost or<br> Amortized<br> Cost |
|  Fixed maturities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Bonds: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; U.S. Treasury securities and obligations of U.S. Government agencies and authorities | $22251 | $24 | $2144 | $— | $24371 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Loan backed and structured securities | 22290 | 17 | 2457 |  | 24730 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Obligations of states and political subdivisions | 7623 | 9 | 1517 |  | 9131 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Corporate securities: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Utilities and telecom | 24623 | 108 | 3206 |  | 27721 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial services | 59564 | 563 | 4768 |  | 63769 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other business – diversified | 34117 | 160 | 3919 |  | 37876 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other consumer – diversified | 41957 | 33 | 6585 |  | 48509 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total corporate securities | 160261 | 864 | 18478 |  | 177875 |
| &nbsp;&nbsp;&nbsp; Redeemable preferred stocks: |  |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Other consumer – diversified | 187 |  | 5 |  | 192 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total redeemable preferred stocks | 187 |  | 5 |  | 192 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total fixed maturities | $212612 | $914 | $24601 | $— | $236299 |

---

Bonds having an amortized cost of $15,368 and $15,065 and included in the tables above were on deposit with insurance regulatory authorities as of September 30, 2025 and December 31, 2024, respectively, in accordance with statutory requirements. In addition, the Company maintains cash and cash equivalents on deposit with insurance regulatory authorities of $0 and $226 as of September 30, 2025 and December 31, 2024, respectively. Additionally, bonds having an amortized cost of $8,954 and $9,209 and included in the tables above were pledged as collateral to the Federal Home Loan Bank of Atlanta ("FHLB") at September 30, 2025 and December 31, 2024, respectively.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

Equity securities were comprised of the following:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | September 30, 2025 | September 30, 2025 | September 30, 2025 | September 30, 2025 |
|  | Estimated<br> Fair Value | Gross<br> Unrealized<br> Gains | Gross<br> Unrealized<br> Losses | Cost or<br> Amortized<br> Cost |
|  Equity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common and non-redeemable preferred stocks: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial services | $1281 | $971 | $— | $310 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Communications | 9151 | 4518 |  | 4633 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total equity securities | $10432 | $5489 | $— | $4943 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | December 31, 2024 | December 31, 2024 | December 31, 2024 | December 31, 2024 |
|  | Estimated<br> Fair Value | Gross<br> Unrealized<br> Gains | Gross<br> Unrealized<br> Losses | Cost or<br> Amortized<br> Cost |
|  Equity securities: |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Common and non-redeemable preferred stocks: |  |  |  |  |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Financial services | $1149 | $843 | $— | $306 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Communications | 6751 | 2118 |  | 4633 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total equity securities | $7900 | $2961 | $— | $4939 |

---

The carrying value and amortized cost of the Company's investments in fixed maturities at September 30, 2025 and December 31, 2024 by contractual maturity were as follows. Actual maturities may differ from contractual maturities because issuers may call or prepay obligations with or without call or prepayment penalties.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | September 30, 2025 | September 30, 2025 | December 31, 2024 | December 31, 2024 |
|  | Carrying<br> Value | Amortized<br> Cost | Carrying<br> Value | Amortized<br> Cost |
|  Due in one year or less | $7915 | $8002 | $7484 | $7497 |
|  Due after one year through five years | 66531 | 67793 | 62722 | 64703 |
|  Due after five years through ten years | 27745 | 28319 | 32820 | 35552 |
|  Due after ten years | 96421 | 107897 | 80199 | 95466 |
|  Asset backed securities | 36857 | 39692 | 29387 | 33081 |
| &nbsp;&nbsp;&nbsp; Totals | $235469 | $251703 | $212612 | $236299 |

---

The following tables present the Company's unrealized loss aging for securities by type and length of time the security was in a continuous unrealized loss position as of September 30, 2025 and December 31, 2024.

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | September 30, 2025 | September 30, 2025 | September 30, 2025 | September 30, 2025 | September 30, 2025 | September 30, 2025 |
|  | Less than 12 months | Less than 12 months | 12 months or longer | 12 months or longer | Total | Total |
|  | Fair<br> Value | Unrealized<br> Losses | Fair<br> Value | Unrealized<br> Losses | Fair<br> Value | Unrealized<br> Losses |
|  U.S. Treasury securities and obligations of U.S. Government agencies and authorities | $739 | $7 | $14050 | $1602 | $14789 | $1609 |
|  Loan backed and structured securities | 850 | 4 | 15802 | 2041 | 16652 | 2045 |
|  Obligations of states and political subdivisions | 406 |  | 5966 | 1389 | 6372 | 1389 |
|  Corporate securities | 11252 | 133 | 120826 | 13106 | 132078 | 13239 |
| &nbsp;&nbsp;&nbsp; Total temporarily impaired securities | $13247 | $144 | $156644 | $18138 | $169891 | $18282 |

---

---

| | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|
|  | December 31, 2024 | December 31, 2024 | December 31, 2024 | December 31, 2024 | December 31, 2024 | December 31, 2024 |
|  | Less than 12 months | Less than 12 months | 12 months or longer | 12 months or longer | Total | Total |
|  | Fair<br> Value | Unrealized<br> Losses | Fair<br> Value | Unrealized<br> Losses | Fair<br> Value | Unrealized<br> Losses |
|  U.S. Treasury securities and obligations of U.S. Government agencies and authorities | $3753 | $33 | $16136 | $2111 | $19889 | $2144 |
|  Loan backed and structured securities | 1010 | 5 | 16069 | 2452 | 17079 | 2457 |
|  Obligations of states and political subdivisions |  |  | 5839 | 1517 | 5839 | 1517 |
|  Corporate securities | 18510 | 755 | 125930 | 17723 | 144440 | 18478 |
|  Redeemable preferred stocks | 188 | 5 |  |  | 188 | 5 |
| &nbsp;&nbsp;&nbsp; Total temporarily impaired securities | $23461 | $798 | $163974 | $23803 | $187435 | $24601 |

---

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

#### Analysis of Securities in Unrealized Loss Positions
As of September 30, 2025 and December 31, 2024, there were 193 and 213 securities, respectively, in an unrealized loss position which primarily included certain of the Company's investments in fixed maturities within the utilities and telecom, financial services, other diversified business and other diversified consumer sectors. The unrealized losses on the Company's fixed maturity securities investments have been primarily related to general market changes in interest rates and/or the levels of credit spreads rather than specific concerns with the issuer's ability to pay interest and repay principal.

For any of its fixed maturity securities with significant declines in fair value, the Company performs detailed analyses to identify whether the drivers of the declines are due to general market drivers, such as the elevated interest rate environment, or due to credit-related factors. Identifying the drivers of the declines in fair value helps to align and allocate the Company's resources to securities with real credit-related concerns that could impact the ultimate collection of principal and interest. For any significant declines in fair value determined to be non-interest rate or market related, the Company performs a more focused review of the related issuers' specific credit profile.

For corporate issuers, the Company evaluates their assets, business profile including industry dynamics and competitive positioning, financial statements and other available financial data. For non-corporate issuers, the Company analyzes all reasonably available sources of credit support, including issuer-specific factors. The Company utilizes information available in the public domain and, for certain private placement issuers, from consultations with the issuers directly. The Company also considers ratings from Nationally Recognized Statistical Rating Organizations, as well as the specific characteristics of the security it owns including seniority in the issuer's capital structure, covenant protections, or other relevant features. From these reviews, the Company evaluates the issuers' continued ability to service the Company's investment through payment of interest and principal.

Assuming no credit-related factors develop, unrealized gains and losses on fixed maturity securities are expected to diminish as investments near maturity. Based on its credit analysis, the Company believes that the issuers of its fixed maturity investments in the sectors shown in the table above have the ability to service their obligations to the Company. In addition, the Company does not intend to sell the investments, and it is not more likely than not that the Company will be required to sell the investments before recovery of their amortized cost bases, which may be at maturity.

However, from time to time the Company identifies certain available-for-sale fixed maturity securities where the amortized cost basis exceeds the present value of the cash flows expected to be collected due to credit related factors and as a result, a credit allowance will be estimated. The Company had no allowance for credit losses ("ACL") on its available-for-sale fixed maturities as of September 30, 2025 or December 31, 2024.

The following tables summarize realized investment gains and losses for the three month and nine month periods ended September 30, 2025 and 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, 2025 | Three Months Ended<br> September 30, 2025 | Three Months Ended<br> September 30, 2025 | Three Months Ended<br> September 30, 2025 |
|  | Fixed<br> Maturities | Equity<br> Securities | Other<br> Invested Assets | Total |
|  Gains | $43 | $— | $— | $43 |
|  Losses | (41) |  |  | (41) |
|  Realized investment gains, net | $2 | $— | $— | $2 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, 2024 | Three Months Ended<br> September 30, 2024 | Three Months Ended<br> September 30, 2024 | Three Months Ended<br> September 30, 2024 |
|  | Fixed<br> Maturities | Equity<br> Securities | Other<br> Invested Assets | Total |
|  Gains | $4 | $— | $— | $4 |
|  Losses |  |  |  |  |
|  Realized investment gains, net | $4 | $— | $— | $4 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Nine Months Ended<br> September 30, 2025 | Nine Months Ended<br> September 30, 2025 | Nine Months Ended<br> September 30, 2025 | Nine Months Ended<br> September 30, 2025 |
|  | Fixed<br> Maturities | Equity<br> Securities | Other<br> Invested Assets | Total |
|  Gains | $196 | $— | $— | $196 |
|  Losses | (178) |  |  | (178) |
|  Realized investment gains, net | $18 | $— | $— | $18 |

---

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Nine Months Ended<br> September 30, 2024 | Nine Months Ended<br> September 30, 2024 | Nine Months Ended<br> September 30, 2024 | Nine Months Ended<br> September 30, 2024 |
|  | Fixed<br> Maturities | Equity<br> Securities | Other<br> Invested Assets | Total |
|  Gains | $19 | $— | $— | $19 |
|  Losses | (2) |  |  | (2) |
|  Realized investment gains, net | $17 | $— | $— | $17 |

---

The following table presents the change in unrealized gains (losses) related to equity securities still held for the three month and nine month periods ended September 30, 2025 and 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
|  Net realized and unrealized gains (losses) recognized during the period on equity securities | $(848) | $(1746) | $2528 | $(1617) |
|  Less: Net realized gains recognized during the period on equity securities sold during the period |  |  |  |  |
| &nbsp;&nbsp;&nbsp; Unrealized gains (losses) recognized during the reporting period on equity securities, net | $(848) | $(1746) | $2528 | $(1617) |

---

#### Variable Interest Entities
The Company holds passive interests in a number of entities that are considered to be variable interest entities ("VIEs") under GAAP guidance. The Company's VIE interests principally consist of interests in limited liability companies formed for the purpose of achieving diversified equity returns. The Company's VIE interests, carried as a part of other invested assets, totaled $6,225 and $6,616 as of September 30, 2025 and December 31, 2024, respectively. The Company's VIE interests, carried as a part of investment in unconsolidated trusts, totaled $1,238 as of September 30, 2025 and December 31, 2024.

The Company does not have power over the activities that most significantly impact the economic performance of these VIEs and thus is not the primary beneficiary. Therefore, the Company has not consolidated these VIEs. The Company's involvement with each VIE is limited to its direct ownership interest in the VIE. The Company's maximum loss exposure relative to these investments was limited to the carrying value of the Company's investment in the VIEs, which amount to $7,463 and $7,854, as of September 30, 2025 and December 31, 2024, respectively. As of September 30, 2025 and December 31, 2024, the Company had outstanding commitments totaling $2,200, respectively, whereby the Company is committed to fund these investments and may be called by the partnership during the commitment period to fund the purchase of new investments and partnership expenses.

---

| | |
|:---|:---|
| **<u>Note 4.</u>** | Fair Values of Financial Instruments |

---

The estimated fair values have been determined by the Company using available market information from various market sources and appropriate valuation methodologies as of the respective dates. However, considerable judgment is necessary to interpret market data and to develop the estimates of fair value. Although management is not aware of any factors that would significantly affect the estimated fair value amounts, the estimates presented herein are not necessarily indicative of the amounts which the Company could realize in a current market exchange. The use of different market assumptions and/or estimation methodologies may have a material effect on the estimated fair value amounts.

The following describes the fair value hierarchy and provides information as to the extent to which the Company uses fair value to measure the value of its financial instruments and information about the inputs used to value those financial instruments. The fair value hierarchy prioritizes the inputs in the valuation techniques used to measure fair value into three broad levels.

---

| | |
|:---|:---|
| Level 1 | Observable inputs that reflect quoted prices for identical assets or liabilities in active markets that the Company has the ability to access at the measurement date. The Company's financial instruments valued using Level 1 criteria include cash equivalents and exchange traded common stocks. |

---

---

| | |
|:---|:---|
| Level 2 | Observable inputs, other than quoted prices included in Level 1, for an asset or liability or prices for similar assets or liabilities. The Company's financial instruments valued using Level 2 criteria include most of its fixed maturities, which consist of U.S. Treasury securities, U.S. Government securities, obligations of states and political subdivisions, and certain corporate fixed maturities, as well as its non-redeemable preferred stocks. In determining fair value measurements of its fixed maturities and non-redeemable preferred stocks using Level 2 criteria, the Company utilizes data from outside sources, including nationally recognized pricing services and broker/dealers. Prices for the majority of the Company's Level 2 fixed maturities and non-redeemable preferred stocks were determined using unadjusted prices received from pricing services that utilize models where the significant inputs are observable (e.g. interest rates, yield curves, prepayment speeds, default rates and loss severities) or can be corroborated by observable market data. |

---

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

---

| | |
|:---|:---|
| Level 3 | Valuations that are derived from techniques in which one or more of the significant inputs are unobservable (including assumptions about risk). Fair value is based on criteria that use assumptions or other data that are not readily observable from objective sources. With little or no observable market, the determination of fair values uses considerable judgment and represents the Company's best estimate of an amount that could be realized in a market exchange for the asset or liability. The Company's financial instruments valued using Level 3 criteria consist of one equity security. As of September 30, 2025 and December 31, 2024, the value of the equity security valued using Level 3 criteria was $193 and $189, respectively. |

---

As of September 30, 2025, financial instruments carried at fair value were measured on a recurring basis as summarized below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Quoted Prices in<br> Active Markets<br> for Identical<br> Assets<br> (Level 1) | Significant<br> Other<br> Observable<br> Inputs<br> (Level 2) | Significant<br> Unobservable<br> Inputs<br> (Level 3) | Total |
|  Assets: |  |  |  |  |
|  Fixed maturities | $— | $235469 | $— | $235469 |
|  Equity securities | 10239 |  | 193 | 10432 |
|  Cash equivalents | 17903 |  |  | 17903 |
| &nbsp;&nbsp;&nbsp; Total | $28142 | $235469 | $193 | $263804 |

---

As of December 31, 2024, financial instruments carried at fair value were measured on a recurring basis as summarized below:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Quoted Prices in<br> Active Markets<br> for Identical<br> Assets<br> (Level 1) | Significant<br> Other<br> Observable<br> Inputs<br> (Level 2) | Significant<br> Unobservable<br> Inputs<br> (Level 3) | Total |
|  Assets: |  |  |  |  |
|  Fixed maturities | $— | $212612 | $— | $212612 |
|  Equity securities | 7711 |  | 189 | 7900 |
|  Cash equivalents | 14948 |  |  | 14948 |
| &nbsp;&nbsp;&nbsp; Total | $22659 | $212612 | $189 | $235460 |

---

The following table sets forth the carrying amount, estimated fair value and level within the fair value hierarchy of the Company's financial instruments as of September 30, 2025 and December 31, 2024.

---

| | | | | | |
|:---|:---|:---|:---|:---|:---|
|  | | September 30, 2025 | September 30, 2025 | December 31, 2024 | December 31, 2024 |
|  | Level in Fair<br> Value<br> Hierarchy <sup>(1)</sup> | Carrying<br> Amount | Estimated<br> Fair Value | Carrying<br> Amount | Estimated<br> Fair Value |
|  Assets: |  |  |  |  |  |
|  Cash and cash equivalents | Level 1 | $34444 | $34444 | $35570 | $35570 |
|  Fixed maturities | Level 2 | 235469 | 235469 | 212612 | 212612 |
|  Equity securities<br><sup>(1)</sup> |  | 10432 | 10432 | 7900 | 7900 |
|  Policy loans | Level 3 | 1668 | 1668 | 1722 | 1722 |
|  Liabilities: |  |  |  |  |  |
|  Junior subordinated debentures, net | Level 2 | 33738 | 34428 | 33738 | 35443 |
|  Revolving credit facility | Level 2 | 4021 | 4021 | 4023 | 4023 |

---

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(1) See the aforementioned information for a description of the fair value hierarchy as well as a description of levels for classes of these financial assets. The Company has one equity security valued at level 3 and all other equity securities are valued at level 1.

The Company had no transfers into or out of level 3 for the nine months ended September 30, 2025 or the year ended December 31, 2024.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

---

| | |
|:---|:---|
| **Note 5**. | Allowance for Expected Credit Losses |

---

Reinsurance Recoverables

The following table presents the balances of reinsurance recoverables, net of the allowance for expected credit losses, at September 30, 2025 and 2024, and the changes in the allowance for expected credit losses for the three month and nine month periods ended September 30, 2025 and 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | At and for the three months ended<br> September 30, 2025 | At and for the three months ended<br> September 30, 2025 | At and for the nine months ended<br> September 30, 2025 | At and for the nine months ended<br> September 30, 2025 |
|  | Reinsurance<br> Recoverables,<br> Net of Allowance<br> for Expected Credit<br> Losses | Allowance for<br> Expected Credit<br> Losses | Reinsurance<br> Recoverables,<br> Net of Allowance<br> for Expected Credit<br> Losses | Allowance for<br> Expected Credit<br> Losses |
|  Balance, beginning of period | $22369 | $43 | $22942 | $51 |
|  Current period change for expected credit losses |  |  |  | (8) |
|  Write-offs of uncollectible reinsurance recoverables |  |  |  |  |
|  Balance, end of period | $22694 | $43 | $22694 | $43 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | At and for the three months ended<br> September 30, 2024 | At and for the three months ended<br> September 30, 2024 | At and for the nine months ended<br> September 30, 2024 | At and for the nine months ended<br> September 30, 2024 |
|  | Reinsurance<br> Recoverables,<br> Net of Allowance<br> for Expected Credit<br> Losses | Allowance for<br> Expected Credit<br> Losses | Reinsurance<br> Recoverables,<br> Net of Allowance<br> for Expected Credit<br> Losses | Allowance for<br> Expected Credit<br> Losses |
|  Balance, beginning of period | $22496 | $54 | $21103 | $61 |
|  Current period change for expected credit losses |  | (1) |  | (8) |
|  Write-offs of uncollectible reinsurance recoverables |  |  |  |  |
|  Balance, end of period | $21600 | $53 | $21600 | $53 |

---

Insurance Premium and Other Receivables

The following table presents the balances of insurance premiums and other, net of the allowance for expected credit losses, at September 30, 2025 and 2024, and the changes in the allowance for expected credit losses for the three month and nine month periods ended September 30, 2025 and 2024.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | At and for the three months ended<br> September 30, 2025 | At and for the three months ended<br> September 30, 2025 | At and for the nine months ended<br> September 30, 2025 | At and for the nine months ended<br> September 30, 2025 |
|  | Insurance Premiums<br> and Other, Net of<br> Expected Credit<br> Losses | Allowance for<br> Expected Credit<br> Losses | Insurance Premiums<br> and Other, Net of<br> Expected Credit<br> Losses | Allowance for<br> Expected Credit<br> Losses |
|  Balance, beginning of period | $50242 | $194 | $27458 | $201 |
|  Current period change for expected credit losses |  | 15 |  | 8 |
|  Write-offs of uncollectible insurance premiums and other receivables |  |  |  |  |
|  Balance, end of period | $42399 | $209 | $42399 | $209 |

---

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | At and for the three months ended<br> September 30, 2024 | At and for the three months ended<br> September 30, 2024 | At and for the nine months ended<br> September 30, 2024 | At and for the nine months ended<br> September 30, 2024 |
|  | Insurance Premiums<br> and Other, Net of<br> Expected Credit<br> Losses | Allowance for<br> Expected Credit<br> Losses | Insurance Premiums<br> and Other, Net of<br> Expected Credit<br> Losses | Allowance for<br> Expected Credit<br> Losses |
|  Balance, beginning of period | $34220 | $219 | $23690 | $217 |
|  Current period change for expected credit losses |  | (4) |  | (2) |
|  Write-offs of uncollectible insurance premiums and other receivables |  |  |  |  |
|  Balance, end of period | $30492 | $215 | $30492 | $215 |

---

---

| | |
|:---|:---|
| **<u>Note 6.</u>** | Internal-Use Software |

---

On March 3, 2021, the Company entered into a hosting arrangement through a service contract with a third party software solutions vendor to provide a suite of policy, billing, claim, and customer management services. The software is managed, hosted, supported, and delivered as a cloud-based software service product offering (software-as-a-service). The initial term of the arrangement, as amended, was three years. The arrangement was renewed in March 2024 for an additional five years, with a subsequent renewal term of five years.

Service fees related to the hosting arrangement are recorded as an expense in the Company's condensed consolidated statement of operations as incurred. Implementation expenses incurred related to third party professional and consulting services have been capitalized. The Company will begin amortizing, on a straight-line basis over the expected remaining term of the hosting arrangement, when the software is substantially ready for its intended use. The Company incurred and capitalized implementation costs of $318 and $78 during the nine months ended September 30, 2025 and 2024, respectively. As a result, the Company has capitalized $4,993 and $4,675 in implementation costs in other assets within its condensed consolidated balance sheet as of September 30, 2025 and December 31, 2024, respectively. The Company expects the software will be substantially ready for its intended use in 2026. Accordingly, the Company has not recorded any amortization expense related to software implementation costs for the three months and nine months ended September 30, 2025 and 2024.

---

| | |
|:---|:---|
| **<u>Note 7.</u>** | Insurance Reserves for Losses and Claims |

---

The roll-forward of insurance reserves for losses and claims for the nine months ended September 30, 2025 and 2024 is as follows:

---

| | | |
|:---|:---|:---|
|  | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 |
|  Beginning insurance reserves for losses and claims, gross | $93707 | $87478 |
|  Less: Reinsurance recoverable on unpaid losses | (17390) | (14678) |
|  Beginning insurance reserves for losses and claims, net | 76317 | 72800 |
|  Incurred related to: |  |  |
| &nbsp;&nbsp;&nbsp; Current accident year | 94705 | 85132 |
| &nbsp;&nbsp;&nbsp; Prior accident year development | (378)<br><sup>(1)</sup> | 3404<br><sup>(2)</sup> |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total incurred | 94327 | 88536 |
|  Paid related to: |  |  |
| &nbsp;&nbsp;&nbsp; Current accident year | 44487 | 40786 |
| &nbsp;&nbsp;&nbsp; Prior accident years | 35604 | 45465 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Total paid | 80091 | 86251 |
|  Ending insurance reserves for losses and claims, net | 90553 | 75085 |
|  Plus: Reinsurance recoverable on unpaid losses | 17160 | 16779 |
|  Ending insurance reserves for losses and claims, gross | $107713 | $91864 |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) Prior years' development was primarily the result of favorable development in the Medicare supplement line of business in the life and health operations, partially offset by unfavorable development in the property and casualty operations predominately in the automobile liability line of business.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

&nbsp;&nbsp;&nbsp;&nbsp;(2) Prior years' development was primarily the result of unfavorable development in the property and casualty operations predominately in the automobile liability line of business due to inflationary factors.

Following is a reconciliation of total losses incurred to total insurance benefits and losses incurred:

---

| | | |
|:---|:---|:---|
|  | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 |
|  Total losses incurred | $94327 | $88536 |
|  Cash surrender value and matured endowments | 1640 | 898 |
|  Benefit reserve changes | 5064 | 5058 |
| &nbsp;&nbsp;&nbsp; Total insurance benefits and losses incurred | $101031 | $94492 |

---

---

| | |
|:---|:---|
| **<u>Note 8</u>.** | Credit Arrangements |

---

#### Bank Debt
On May 12, 2021, the Company entered into a Revolving Credit Agreement with Truist Bank as the lender (the "Lender"). The Revolving Credit Agreement provides for an unsecured $10,000 revolving credit facility that originally matured on April 12, 2024. On March 22, 2024, the Company entered into a First Amendment (the "Amendment") to its Revolving Credit Agreement (as amended, the "Credit Agreement") with the Lender. The Amendment, among other things, (a) updates the interest rate provisions to memorialize that the Company pays interest on the unpaid principal balance of outstanding revolving loans at the Adjusted Term SOFR rate (as defined in the Credit Agreement), plus 2.00%, (b) extends the maturity date of the revolving credit facility to March 22, 2027, (c) requires the monthly payment of an unused commitment fee of 0.2% of the unused facility amount, and (d) requires that the Company maintain a consolidated net worth of not less than $64,200. Except as modified by the Amendment, the existing terms of the original Credit Agreement remain in effect.

The Credit Agreement requires the Company to comply with certain covenants, including a debt-to-capital ratio that restricts the Company from incurring consolidated indebtedness that exceeds 35% of the Company's consolidated capitalization at any time and maintaining a minimum consolidated net worth, as previously mentioned. The Credit Agreement also contains customary representations and warranties and events of default. Events of default include, among others, (a) the failure by the Company to pay any amounts owed under the Credit Agreement when due, (b) the failure to perform and not timely remedy certain covenants, (c) a change in control of the Company and (d) the occurrence of bankruptcy or insolvency events. Upon an event of default, the Lender may, among other things, declare all obligations under the Credit Agreement immediately due and payable and terminate the revolving commitments. As of September 30, 2025, and December 31, 2024, the Company had outstanding borrowings including accrued interest of $4,021 and $4,023, respectively, under the Credit Agreement.

For the three months ended September 30, 2025 and 2024, the Company incurred $66 and $76 in interest expense, respectively, on the revolving credit facility borrowing. For the nine months ended September 30, 2025 and 2024, the Company incurred $195 and $213, respectively, in interest expense. In each of the three months ended September 30, 2025 and 2024, the Company paid $3 in fees on the available unused amount ("unused commitment fees") of the revolving credit facility of $6,000. During the nine months ended September 30, 2025 and 2024, the Company paid $9 and $6, respectively, in unused commitment fees. At September 30, 2025 and December 31, 2024, the effective interest rate was 6.42% and 6.67%, respectively.

#### Junior Subordinated Debentures
The Company has two unconsolidated Connecticut statutory business trusts, which exist for the exclusive purposes of: (i) issuing trust preferred securities ("Trust Preferred Securities") representing undivided beneficial interests in the assets of the trusts; (ii) investing the gross proceeds of the Trust Preferred Securities in junior subordinated deferrable interest debentures ("Junior Subordinated Debentures") of the Company; and (iii) engaging in those activities necessary or incidental thereto.

The outstanding $18,042 and $15,696 of Junior Subordinated Debentures mature on December 4, 2032 and May 15, 2033, respectively, are callable quarterly, in whole or in part, only at the option of the Company. Prior to July 1, 2023, the interest rate was based on 3-month LIBOR plus an applicable margin. Effective July 1, 2023, the interest rate is determined based on a reference rate of the 3-month SOFR plus applicable tenor spread of 0.26161% plus an applicable margin, ranging from 4.00% to 4.10%. At September 30, 2025 and December 31, 2024, the effective interest rate was 8.51% and 8.82%, respectively.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

The financial structure of each of Atlantic American Statutory Trust I and II as of September 30, 2025 was as follows:

---

| | | |
|:---|:---|:---|
|  | Atlantic American<br> Statutory Trust I | Atlantic American<br> Statutory Trust II |
|  JUNIOR SUBORDINATED DEBENTURES <sup>(1) (2)</sup> |  |  |
|  Principal amount owed September 30, 2025 | $18042 | $23196 |
|  Less: Treasury debt <sup>(3)</sup> |  | (7500) |
|  Net balance September 30, 2025 | $18042 | $15696 |
|  Net balance December 31, 2024 | $18042 | $15696 |
|  Coupon rate | 3-Month SOFR + 0.26161% spread adj + 4.00% | 3-Month SOFR + 0.26161% spread adj + 4.10% |
|  Interest payable | Quarterly | Quarterly |
|  Maturity date | December 4, 2032 | May 15, 2033 |
|  Redeemable by issuer | Yes | Yes |
|  TRUST PREFERRED SECURITIES |  |  |
|  Issuance date | December 4, 2002 | May 15, 2003 |
|  Securities issued | 17500 | 22500 |
|  Liquidation preference per security | $1 | $1 |
|  Liquidation value | $17500 | $22500 |
|  Coupon rate | 3-Month SOFR + 0.26161% spread adj + 4.00% | 3-Month SOFR + 0.26161% spread adj + 4.10% |
|  Distribution payable | Quarterly | Quarterly |
|  Distribution guaranteed by <sup>(4)</sup> | Atlantic American Corporation | Atlantic American Corporation |

---

&nbsp;&nbsp;&nbsp;&nbsp;(1) For each of the respective debentures, the Company has the right at any time, and from time to time, to defer payments of interest on the Junior Subordinated Debentures for a period not exceeding 20 consecutive quarters up to the debentures' respective maturity dates. During any such period, interest will continue to accrue and the Company may not declare or pay any cash dividends or distributions on, or purchase, the Company's common stock nor make any principal, interest or premium payments on or repurchase any debt securities that rank equally with or junior to the Junior Subordinated Debentures. The Company has the right at any time to dissolve each of the trusts and cause the Junior Subordinated Debentures to be distributed to the holders of the Trust Preferred Securities.

&nbsp;&nbsp;&nbsp;&nbsp;(2) The Junior Subordinated Debentures are unsecured and rank junior and subordinate in right of payment to all senior debt of the Parent and are effectively subordinated to all existing and future liabilities of its subsidiaries.

&nbsp;&nbsp;&nbsp;&nbsp;(3) On August 4, 2014, the Company acquired $7,500 of the Junior Subordinated Debentures.

&nbsp;&nbsp;&nbsp;&nbsp;(4) The Parent has guaranteed, on a subordinated basis, all of the obligations under the Trust Preferred Securities, including payment of the redemption price and any accumulated and unpaid distributions to the extent of available funds and upon dissolution, winding up or liquidation.

---

| | |
|:---|:---|
| **<u>Note 9</u>.** | Earnings (Loss) Per Common Share |

---

A reconciliation of the numerator and denominator used in the earnings (loss) per common share calculations is as follows:

---

| | | | |
|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, 2025 | Three Months Ended<br> September 30, 2025 | Three Months Ended<br> September 30, 2025 |
|  | Earnings | Weighted<br> Average Shares<br> (In thousands) | Per Share<br> Amount |
|  *Basic and Diluted Earnings Per Common Share:* |  |  |  |
|  Net income | $577 | 20397 |  |
|  Less preferred stock dividends | (100) |  |  |
| &nbsp;&nbsp;&nbsp; Net income applicable to common shareholders | $477 | 20397 | $0.02 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, 2024 | Three Months Ended<br> September 30, 2024 | Three Months Ended<br> September 30, 2024 |
|  | Loss | Weighted<br> Average Shares<br> (In thousands) | Per Share<br> Amount |
|  *Basic and Diluted Loss Per Common Share:* |  |  |  |
|  Net loss | $(1998) | 20400 |  |
|  Less preferred stock dividends | (100) |  |  |
| &nbsp;&nbsp;&nbsp; Net loss applicable to common shareholders | $(2098) | 20400 | $(0.10) |

---

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

---

| | | | |
|:---|:---|:---|:---|
|  | Nine Months Ended<br> September 30, 2025 | Nine Months Ended<br> September 30, 2025 | Nine Months Ended<br> September 30, 2025 |
|  | Earnings | Weighted<br> Average Shares<br> (In thousands) | Per Share<br> Amount |
|  *Basic and Diluted Earnings Per Common Share:* |  |  |  |
|  Net income | $4695 | 20398 |  |
|  Less preferred stock dividends | (299) |  |  |
| &nbsp;&nbsp;&nbsp; Net income applicable to common shareholders | $4396 | 20398 | $0.22 |

---

---

| | | | |
|:---|:---|:---|:---|
|  | Nine Months Ended<br> September 30, 2024 | Nine Months Ended<br> September 30, 2024 | Nine Months Ended<br> September 30, 2024 |
|  | Loss | Weighted<br> Average Shares<br> (In thousands) | Per Share<br> Amount |
|  *Basic and Diluted Loss Per Common Share:* |  |  |  |
|  Net loss | $(4680) | 20401 |  |
|  Less preferred stock dividends | (299) |  |  |
| &nbsp;&nbsp;&nbsp; Net loss applicable to common shareholders | $(4979) | 20401 | $(0.24) |

---

The assumed conversion of the Company's Series D preferred stock was excluded from the earnings (loss) per common share calculation, since its impact would have been antidilutive.

---

| | |
|:---|:---|
| **<u>Note 10.</u>** | Income Taxes |

---

A reconciliation of the differences between income taxes computed at the federal statutory income tax rate and income tax expense (benefit) is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
|  Federal income tax provision at statutory rate of 21% | $160 | $(515) | $1263 | $(1220) |
|  Dividends-received deduction | (6) | (10) | (18) | (22) |
|  Meals and entertainment | 27 | 18 | 56 | 53 |
|  Vested stock and club dues |  |  | 2 | 1 |
|  Parking disallowance | 8 | 7 | 19 | 15 |
|  Adjustment for prior years' estimates to actual | 3 | 44 | 3 | 44 |
| &nbsp;&nbsp;&nbsp; Income tax expense (benefit) | $192 | $(456) | $1325 | $(1129) |

---

The components of income tax expense (benefit) were:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
|  Current – Federal | $588 | $296 | $861 | $296 |
|  Deferred – Federal | (396) | (752) | 464 | (1425) |
| &nbsp;&nbsp;&nbsp; Total | $192 | $(456) | $1325 | $(1129) |

---

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

---

| | |
|:---|:---|
| **<u>Note 11.</u>** | Leases |

---

The Company has three operating lease agreements, each for the use of office space in the ordinary course of business. The original term of the first lease was to automatically renew on an annual basis and was amended on December 26, 2024, when the Company and its subsidiary, Bankers Fidelity Life Insurance Company, entered into a Second Amendment to the Lease Agreement (the "Second Amendment") with 4370 Peachtree LLC. The Second Amendment amends the Lease Agreement, dated November 1, 2007, by and among the same parties (as previously amended, the "Lease Agreement"), pursuant to which the Company leases space for its principal offices and for some of its insurance operations in an office building located in Atlanta, Georgia. Pursuant to the Second Amendment, the Lease Agreement was modified to increase the base rent payable by the Company, beginning January 1, 2025. The Second Amendment also provides for rent adjustment on January 1, 2027, January 1, 2030 and each five years thereafter.

The original term of the second lease was ten years and amended in January 2017 to provide for an additional seven years, with a termination date on September 30, 2026. The rate used in determining the present value of lease payments is based upon an estimate of the Company's incremental secured borrowing rate commensurate with the term of the underlying lease.

The original term of the third lease was three years and renewed for an additional three years, effective August 1, 2025 with a termination date on July 31, 2028. The rate used in determining the present value of lease payments is based upon an estimate of the Company's incremental secured borrowing rate commensurate with the term of the underlying lease.

These leases are accounted for as operating leases, whereby lease expense is recognized on a straight-line basis over the term of the lease. Lease expense reported for the nine months ended September 30, 2025 and September 30, 2024 was $890 and $761, respectively.

Additional information regarding the Company's real estate operating leases is as follows:

---

| | | |
|:---|:---|:---|
|  | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 |
|  Cash payments included in the measurement of lease liabilities reported in operating cash flows | $939 | $797 |
|  Right-of-use assets included in other assets on the condensed consolidated balance sheet | 4823 | 1981 |
|  Weighted average discount rate | 7.9% | 6.8% |
|  Weighted average remaining lease term in years | 7.0 years | 2.1 years |

---

The following table presents maturities and present value of the Company's lease liabilities:

---

| | |
|:---|:---|
|  | Lease Liability |
|  Remainder of 2025 | $315 |
| 2026 | 1113 |
| 2027 | 693 |
| 2028 | 673 |
| 2029 | 645 |
|  Thereafter | 3595 |
| &nbsp;&nbsp;&nbsp; Total undiscounted lease payments | 7034 |
|  Less: present value adjustment | 2129 |
| &nbsp;&nbsp;&nbsp; Operating lease liability included in accounts payable and accrued expenses on the condensed consolidated balance sheet | $4905 |

---

As of September 30, 2025, the Company has no operating leases that have not yet commenced.

---

| | |
|:---|:---|
| **<u>Note 12.</u>** | Commitments and Contingencies |

---

#### Litigation
From time to time, the Company is, and expects to continue to be, involved in various claims and lawsuits incidental to and arising in the ordinary course of its business. In the opinion of management, any such known claims are not expected to have a material effect on the financial condition or results of operations of the Company.

#### Regulatory Matters
Like all domestic insurance companies, the Company's insurance subsidiaries are subject to regulation and supervision in the jurisdictions in which they do business. Statutes typically delegate regulatory, supervisory, and administrative powers to state insurance commissioners. From time to time, and in the ordinary course of business, the Company receives notices and inquiries from state insurance departments with respect to various matters. In the opinion of management, any such known regulatory matters are not expected to have a material effect on the financial condition or results of operations of the Company.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

---

| | |
|:---|:---|
| **<u>Note 13.</u>** | Segment Information |

---

The Parent's primary insurance subsidiaries operate with relative autonomy and each company is evaluated based on its individual performance. American Southern operates in the property and casualty insurance market, while Bankers Fidelity operates in the life and health insurance market. Each segment derives revenue from the collection of premiums, as well as from investment income. The Company's strategy is to focus on well-defined geographic, demographic and/or product niches within the insurance marketplace. Substantially all revenue other than that in the corporate and other segment is from external sources.

The Company adopted ASU No. 2023-07, Segment Reporting- An Amendment for Improvements to Reportable Segment Disclosures (Topic 280) in December 2024. The most significant provision was for the Company to disclose significant segment expenses that are regularly provided to the Chief Operating Decision Maker ("CODM"). The Company's CODM is the Chairman, President and Chief Executive Officer. The segment's most significant expenses include insurance benefits and losses incurred and other expenses, such as commissions and underwriting. Interest expense at the segment level is insignificant. To assess proﬁtability on a reportable segment basis, the CODM reviews income (loss) before income taxes.

The following sets forth the assets, revenue and income (loss) before income taxes for each business unit as of and for the periods ended 2025 and 2024.

---

| | | |
|:---|:---|:---|
|  **Assets** | September 30,<br> 2025 | December 31,<br> 2024 |
|  American Southern | $168631 | $147214 |
|  Bankers Fidelity | 229859 | 210819 |
|  Corporate, Other and Eliminations | 32365 | 35395 |
| &nbsp;&nbsp;&nbsp; Total assets | $430855 | $393428 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  **Revenues** | 2025 | 2024 | 2025 | 2024 |
|  American Southern | $23671 | $17282 | $65324 | $54666 |
|  Bankers Fidelity | 29972 | 27125 | 93562 | 84499 |
|  Corporate, Other and Eliminations | 117 | 112 | 289 | 19 |
| &nbsp;&nbsp;&nbsp; Total revenue | $53760 | $44519 | $159175 | $139184 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  **Insurance benefits and losses incurred** | 2025 | 2024 | 2025 | 2024 |
|  American Southern | $17962 | $13984 | $48572 | $41025 |
|  Bankers Fidelity | 17509 | 16776 | 52459 | 53467 |
|  Corporate, Other and Eliminations | - | - | - | - |
| &nbsp;&nbsp;&nbsp; Total insurance benefits and losses incurred | $35471 | $30760 | $101031 | $94492 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  **Commissions and underwriting** | 2025 | 2024 | 2025 | 2024 |
|  American Southern | $4146 | $3790 | $13562 | $11808 |
|  Bankers Fidelity | 10828 | 9980 | 31161 | 30756 |
|  Corporate, Other and Eliminations | (2019) | (2280) | (7218) | (6824) |
| &nbsp;&nbsp;&nbsp; Total commissions and underwriting | $12955 | $11490 | $37505 | $35740 |

---

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  **Income (loss) before income taxes** | 2025 | 2024 | 2025 | 2024 |
|  American Southern | $1630 | $(528) | $3190 | $1730 |
|  Bankers Fidelity | 1634 | 367 | 9941 | 275 |
|  Corporate, Other and Eliminations | (2495) | (2293) | (7111) | (7814) |
| &nbsp;&nbsp;&nbsp; Income (loss) before income taxes | $769 | $(2454) | $6020 | $(5809) |

---

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

<u>Item 2.</u>

#### MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION

#### AND RESULTS OF OPERATIONS

#### Overview
The following is management's discussion and analysis of the financial condition and results of operations of Atlantic American Corporation ("Atlantic American" or the "Parent") and its subsidiaries (collectively with the Parent, the "Company") as of and for the three month and nine month periods ended September 30, 2025. This discussion should be read in conjunction with the unaudited condensed consolidated financial statements and notes thereto included elsewhere herein, as well as with the audited consolidated financial statements and notes included in the Company's Annual Report on Form 10-K for the year ended December 31, 2024 (the "2024 Annual Report").

Atlantic American is an insurance holding company whose operations are conducted primarily through its insurance subsidiaries: American Southern Insurance Company and American Safety Insurance Company (together known as "American Southern") and Bankers Fidelity Life Insurance Company, Bankers Fidelity Assurance Company and Atlantic Capital Life Assurance Company (together known as "Bankers Fidelity"). Each operating company is managed separately, offers different products and is evaluated on its individual performance.

#### Critical Accounting Policies
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America ("GAAP") requires management to make estimates and assumptions that affect reported amounts and related disclosures. Actual results could differ significantly from those estimates. The Company has identified certain estimates that involve a higher degree of judgment and are subject to a significant degree of variability. The Company's critical accounting policies and the resultant estimates considered most significant by management are disclosed in the 2024 Annual Report. Except as disclosed in Note 1 of Notes to Condensed Consolidated Financial Statements, the Company's critical accounting policies are consistent with those disclosed in the 2024 Annual Report.

#### Overall Corporate Results
The following presents the Company's revenue, expenses and net income (loss) for the three month and nine month periods ended September 30, 2025 and the comparable periods in 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br>September 30, | Three Months Ended<br>September 30, | Nine Months Ended<br>September 30, | Nine Months Ended<br>September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
|  (In thousands) |  |  |  |  |
|  Insurance premiums, net | $51972 | $43782 | $149031 | $133327 |
|  Net investment income | 2633 | 2477 | 7591 | 7449 |
|  Realized investment gains, net | 2 | 4 | 18 | 17 |
|  Unrealized gains (losses) on equity securities, net | (848) | (1746) | 2528 | (1617) |
|  Other income | 1 | 2 | 7 | 8 |
| &nbsp;&nbsp;&nbsp; Total revenue | 53760 | 44519 | 159175 | 139184 |
|  Insurance benefits and losses incurred | 35471 | 30760 | 101031 | 94492 |
|  Commissions and underwriting expenses | 12955 | 11490 | 37505 | 35740 |
|  Interest expense | 779 | 869 | 2326 | 2591 |
|  Other expense | 3786 | 3854 | 12293 | 12170 |
| &nbsp;&nbsp;&nbsp; Total benefits and expenses | 52991 | 46973 | 153155 | 144993 |
|  Income (loss) before income taxes | $769 | $(2454) | $6020 | $(5809) |
|  Net income (loss) | $577 | $(1998) | $4695 | $(4680) |

---

In addition to measures of operating performance determined in accordance with GAAP, management also considers and evaluates performance by analyzing the non-GAAP measure operating income (loss). We define operating income (loss) as net income (loss) excluding: (i) income tax expense (benefit); (ii) realized investment (gains) losses, net; and (iii) unrealized (gains) losses on equity securities, net. Management believes operating income (loss) is a useful metric for investors, potential investors, securities analysts and others because it isolates the "core" operating results of the Company before considering certain items that are either beyond the control of management (such as taxes, which are subject to timing, regulatory and rate changes depending on the timing of the associated revenues and expenses) or are not expected to regularly impact the Company's operational results (such as any realized and unrealized investment gains, which are not a part of the Company's primary operations and are, to a limited extent, subject to discretion in terms of timing of realization).

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

A reconciliation of net income (loss) to operating income (loss) for the three month and nine month periods ended September 30, 2025 and the comparable periods in 2024 is as follows:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br>September 30, | Three Months Ended<br>September 30, | Nine Months Ended<br>September 30, | Nine Months Ended<br>September 30, |
|  Reconciliation of Non-GAAP Financial Measure | 2025 | 2024 | 2025 | 2024 |
|  | (In thousands) | (In thousands) | (In thousands) | (In thousands) |
|  Net income (loss) | $577 | $(1998) | $4695 | $(4680) |
|  Income tax expense (benefit) | 192 | (456) | 1325 | (1129) |
|  Realized investment gains, net | (2) | (4) | (18) | (17) |
|  Unrealized (gains) losses on equity securities, net | 848 | 1746 | (2528) | 1617 |
|  Non-GAAP operating income (loss) | $1615 | $(712) | $3474 | $(4209) |

---

On a consolidated basis, the Company had net income of $0.6 million, or $0.02 per diluted share, for the three month period ended September 30, 2025, compared to net loss of $2.0 million, or $(0.10) per diluted share, for the three month period ended September 30, 2024. The Company had net income of $4.7 million, or $0.22 per diluted share, for the nine month period ended September 30, 2025, compared to net loss of $4.7 million, or $(0.24) per diluted share, for the nine month period ended September 30, 2024. The increase in net income for the three month and nine month periods ended September 30, 2025 was primarily the result of increases in premium revenue within the automobile liability, inland marine and automobile physical damage lines of business in the property and casualty operations, as well as increases in the Medicare supplement and group accident and health lines of business within the life and health operations. Also contributing to the increase in net income was an increase in unrealized gains on equity securities during the three month and nine month periods ended September 30, 2025.

For the three month period ended September 30, 2025, premium revenue increased $8.2 million, or 18.7%, to $52.0 million from $43.8 million in the comparable period in 2024. For the nine month period ended September 30, 2025, premium revenue increased $15.7 million, or 11.8%, to $149.0 million from $133.3 million in the comparable period in 2024. The increase in premium revenue during the three month and nine month periods ended September 30, 2025 was primarily attributable to the increase in earned premiums within the automobile liability line of business, as well as increases in earned premiums in the inland marine and automobile physical damage lines of business, due to increases in premium writings in the property and casualty operations. Also contributing to the increase in premium revenue was increases in the Medicare supplement and group accident and health lines of business due to new sales within the life and health operations.

Operating income increased $2.3 million in the three month period ended September 30, 2025 from the three month period ended September 30, 2024. For the nine month period ended September 30, 2025, operating income increased $7.7 million from the comparable period in 2024. The increase in operating income for the three month and nine month periods ended September 30, 2025 was primarily the result of increases in premium revenue in the automobile liability, inland marine and automobile physical damage lines of business within the property and casualty operations, as well as increases in the Medicare supplement and group accident and health lines of business within the life and health operations, as previously mentioned.

A more detailed analysis of the individual operating segments and other corporate activities follows.

#### American Southern
The following summarizes American Southern's premiums, losses, expenses and underwriting ratios for the three month and nine month periods ended September 30, 2025 and the comparable periods in 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br>September 30, | Three Months Ended<br>September 30, | Nine Months Ended<br>September 30, | Nine Months Ended<br>September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
|  | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  Gross written premiums | $10185 | $8533 | $71806 | $53502 |
|  Ceded premiums | (1419) | (1435) | (4496) | (4393) |
| &nbsp;&nbsp;&nbsp; Net written premiums | $8766 | $7098 | $67310 | $49109 |
|  Net earned premiums | $22500 | $16214 | $61972 | $51636 |
|  Insurance benefits and losses incurred | 17962 | 13984 | 48572 | 41025 |
|  Commissions and underwriting expenses | 4079 | 3826 | 13562 | 11911 |
| &nbsp;&nbsp;&nbsp; Underwriting income (loss) | $459 | $(1596) | $(162) | $(1300) |
|  Loss ratio | 79.8% | 86.2% | 78.4% | 79.5% |
|  Expense ratio | 18.1 | 23.6 | 21.9 | 23.1 |
| &nbsp;&nbsp;&nbsp; Combined ratio | 97.9% | 109.8% | 100.3% | 102.6% |

---

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

Gross written premiums at American Southern increased $1.7 million, or 19.4%, during the three month period ended September 30, 2025 and $18.3 million, or 34.2%, during the nine month period ended September 30, 2025, from the comparable periods in 2024. The increase in gross written premiums during the three month and nine month periods ended September 30, 2025 was primarily attributable to an increase in premiums written in the automobile liability line of business due to the renewal of a program, which included a rate increase. Also contributing to the increase in gross written premiums were increases in premiums written in the inland marine line of business due to a new program written by an existing agency, as well as an increase in premiums written in the automobile physical damage line of business resulting from an increase in writings from existing agents.

Ceded premiums remained constant during the three month period ended September 30, 2025 and increased $0.1 million, or 2.3%, during the nine month period ended September 30, 2025, from the comparable periods in 2024. American Southern's ceded premiums are typically determined as a percentage of earned premiums and generally fluctuate as earned premiums subject to reinsurance increase or decrease or retentions levels change.

The following presents American Southern's net earned premiums by line of business for the three month and nine month periods ended September 30, 2025 and the comparable periods in 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
|  | (In thousands) | (In thousands) | (In thousands) | (In thousands) |
|  Automobile liability | $13541 | $9659 | $35540 | $31311 |
|  Automobile physical damage | 3984 | 3056 | 12131 | 9678 |
|  General liability | 1500 | 1529 | 4581 | 4550 |
|  Surety | 1252 | 1377 | 3997 | 4336 |
|  Inland Marine | 2223 | 593 | 5723 | 1761 |
| &nbsp;&nbsp;&nbsp; Total | $22500 | $16214 | $61972 | $51636 |

---

Net earned premiums increased $6.3 million, or 38.8%, during the three month period ended September 30, 2025, and $10.3 million, or 20.0%, during the nine month period ended September 30, 2025, over the comparable periods in 2024. The increase in net earned premiums during the three month and nine month periods ended September 30, 2025 was mainly due to a rate increase upon renewal of a program within the automobile liability line of business, as well as increases in earned premiums in the inland marine and automobile physical damage lines of business, due to increases in premium writings, as previously mentioned. Premiums are earned ratably over their respective policy terms, and therefore premiums earned in the current year are related to policies written during both the current year and immediately preceding year.

The performance of an insurance company is often measured by its combined ratio. The combined ratio represents the percentage of losses, loss adjustment expenses and other expenses that are incurred for each dollar of premium earned by the company. A combined ratio of under 100% represents an underwriting profit while a combined ratio of over 100% indicates an underwriting loss. The combined ratio is divided into two components, the loss ratio (the ratio of losses and loss adjustment expenses incurred to premiums earned) and the expense ratio (the ratio of expenses incurred to premiums earned).

Insurance benefits and losses incurred at American Southern increased $4.0 million, or 28.4%, during the three month period ended September 30, 2025, and $7.5 million, or 18.4%, during the nine month period ended September 30, 2025, over the comparable periods in 2024. As a percentage of earned premiums, insurance benefits and losses incurred were 79.8% in the three month period ended September 30, 2025, compared to 86.2% in the three month period ended September 30, 2024. For the nine month period ended September 30, 2025, this ratio decreased to 78.4% from 79.5% in the comparable period in 2024. The decrease in the loss ratios during the three month and nine month periods ended September 30, 2025 was due to an increase in premium growth exceeding the increase in insurance benefits and losses incurred.

Commissions and underwriting expenses increased $0.3 million, or 6.6%, during the three month period ended September 30, 2025, and $1.7 million, or 13.9% during the nine month period ended September 30, 2025, over the comparable periods in 2024. As a percentage of earned premiums, underwriting expenses were 18.1% in the three month period ended September 30, 2025, compared to 23.6% in the three month period ended September 30, 2024. For the nine month period ended September 30, 2025, this ratio decreased to 21.9% from 23.1% in the comparable period in 2024. American Southern uses a variable commission structure with certain agents, which compensates the participating agents in relation to the loss ratios of the business they write. During periods in which the loss ratio decreases, commissions and underwriting expenses will generally increase, and conversely, during periods in which the loss ratio increases, commissions and underwriting expenses will generally decrease. However, during the three month and nine month periods ended September 30, 2025, the expense ratio decreased primarily due to an increase in premiums on programs that do not participate in the variable commission structure.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

#### Bankers Fidelity
The following summarizes Bankers Fidelity's earned premiums, losses, expenses and underwriting ratios for the three month and nine month periods ended September 30, 2025 and the comparable periods in 2024:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br> September 30, | Three Months Ended<br> September 30, | Nine Months Ended<br> September 30, | Nine Months Ended<br> September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
|  | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) | (Dollars in thousands) |
|  Gross earned premiums | $45603 | $40872 | $132021 | $121229 |
|  Ceded premiums | (16131) | (13304) | (44962) | (39538) |
| &nbsp;&nbsp;&nbsp; Net earned premiums | 29472 | 27568 | 87059 | 81691 |
|  Insurance benefits and losses incurred | 17509 | 16776 | 52459 | 53467 |
|  Commissions and underwriting expenses | 10828 | 9980 | 31161 | 30756 |
| &nbsp;&nbsp;&nbsp; Total expenses | 28337 | 26756 | 83620 | 84223 |
| &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Underwriting income (loss) | $1135 | $812 | $3439 | $(2532) |
|  Loss ratio | 59.4% | 60.9% | 60.3% | 65.5% |
|  Expense ratio | 36.7 | 36.2 | 35.8 | 37.6 |
| &nbsp;&nbsp;&nbsp; Combined ratio | 96.1% | 97.1% | 96.1% | 103.1% |

---

Gross earned premiums increased $4.7 million, or 11.6%, during the three month period ended September 30, 2025, and $10.8 million, or 8.9%, during the nine month period ended September 30, 2025, from the comparable periods in 2024. The increase in gross earned premiums was primarily attributable to the increase in gross earned premiums from the Medicare supplement line of business due primarily to the level of new business writings exceeding non-renewals, partially offset by lapses within the same line of business. Also contributing to the increase in gross earned premiums was an increase in gross earned premiums in the group accident and health line of business, resulting from new business sales.

Ceded premiums increased $2.8 million, or 21.2%, during the three month period ended September 30, 2025, and $5.4 million, or 13.7%, during the nine month period ended September 30, 2025, from the comparable periods in 2024. The increase in ceded premiums was due to an increase in Medicare supplement premiums subject to reinsurance.

The following table summarizes, for the periods indicated, Bankers Fidelity's net earned premiums by line of business:

---

| | | | | |
|:---|:---|:---|:---|:---|
|  | Three Months Ended<br>September 30, | Three Months Ended<br>September 30, | Nine Months Ended<br>September 30, | Nine Months Ended<br>September 30, |
|  | 2025 | 2024 | 2025 | 2024 |
|  | (In thousands) | (In thousands) | (In thousands) | (In thousands) |
|  Medicare supplement | $20265 | $17947 | $57755 | $53914 |
|  Group life | 3314 | 3999 | 10881 | 11831 |
|  Individual life | 1357 | 1374 | 4261 | 4249 |
|  Group accident and health | 2270 | 2327 | 7578 | 6212 |
|  Other individual accident and health | 2266 | 1921 | 6584 | 5485 |
| &nbsp;&nbsp;&nbsp; Total | $29472 | $27568 | $87059 | $81691 |

---

Net earned premium increased $1.9 million, or 6.9%, during the three month period ended September 30, 2025, and $5.4 million, or 6.6%, during the nine month period ended September 30, 2025, over the comparable periods in 2024. The increase in net earned premiums was primarily attributable to increases in the Medicare supplement and group accident and health lines of business due to new sales as previously mentioned. Also contributing to the increase in net earned premiums was an increase in the other individual accident and health line of business due to new business growth.

Insurance benefits and losses incurred increased $0.7 million, or 4.4%, during the three month period ended September 30, 2025, and decreased $1.0 million, or 1.9%, during the nine month period ended September 30, 2025, from the comparable periods in 2024. As a percentage of earned premiums, benefits and losses were 59.4% in the three month period ended September 30, 2025, compared to 60.9% in the three month period ended September 30, 2024. For the nine month period ended September 30, 2025, this ratio decreased to 60.3% from 65.5% in the comparable period in 2024. The decrease in the loss ratio for the three month and nine month periods ended September 30, 2025 was primarily due to rate increases on renewals and lower utilization within the Medicare supplement line of business.

Commissions and underwriting expenses increased $0.8 million, or 8.5%, during the three month period ended September 30, 2025, and $0.4 million, or 1.3%, during the nine month period ended September 30, 2025, over the comparable periods in 2024. As a percentage of earned premiums, underwriting expenses were 36.7% in the three month period ended September 30, 2025, compared to 36.2% in the three month period ended September 30, 2024. For the nine month period ended September 30, 2025, this ratio decreased to 35.8% from 37.6% in the comparable period in 2024. The increase in the expense ratio for the three month period ended September 30, 2025 was primarily due to an increase in commissions and underwriting expenses due to premium growth. The decrease in the expense ratio for the nine month period ended September 30, 2025 was primarily due to growth in premiums coupled with a decline in underwriting expenses.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

#### Net Investment Income and Realized Gains
Investment income increased $0.2 million, or 6.3%, during the three month period ended September 30, 2025, and remained constant during the nine month period ended September 30, 2025, over the comparable periods in 2024. The increase in investment income in the three month period ended September 30, 2025, from the comparable periods in 2024, was primarily attributable to an increase in the equity in earnings from investments in the Company's limited partnerships and limited liability companies.

The Company had net realized investment gains of less than $0.1 million during each of the three month and nine month periods ended September 30, 2025, compared to net realized investment gains of less than $0.1 million during each of the three month and nine month periods ended September 30, 2024. The net realized investment gains during the three month and nine month periods ended September 30, 2025 was due to the sale and redemption of several of the Company's investments in fixed maturity securities. The net realized investment gains during the three month and nine month periods ended September 30, 2024 resulted primarily from the redemption of several of the Company's investments in fixed maturity securities. Management continually evaluates the Company's investment portfolio and makes adjustments for credit losses and/or divests investments as may be determined to be appropriate.

#### Unrealized Gains (Losses) on Equity Securities
Investments in equity securities are measured at fair value at the end of the reporting period, with any changes in fair value reported in net income during the period. The Company recognized net unrealized losses on equity securities of $0.8 million during the three month period ended September 30, 2025 and unrealized losses on equity securities of $1.7 million during the three month period ended September 30, 2024. The Company recognized net unrealized gains on equity securities of $2.5 million during the nine month period ended September 30, 2025 and unrealized losses on equity securities of $1.6 million during the nine month period ended September 30, 2024. Changes in unrealized gains (losses) on equity securities for the applicable periods are the result of fluctuations in the market value of the Company's equity securities.

#### Interest Expense
Interest expense decreased $0.1 million, or 10.4%, during the three month period ended September 30, 2025, and $0.3 million, or 10.2%, during the nine month period ended September 30, 2025, from the comparable periods in 2024. Changes in interest expense were primarily due to changes in the Secured Overnight Financing Rate ("SOFR") published by CME Group Benchmark Administration Limited, as the interest rates on the Company's outstanding junior subordinated deferrable interest debentures ("Junior Subordinated Debentures") and the revolving credit facility utilize SOFR as the reference rate.

#### Liquidity and Capital Resources
The primary cash needs of the Company are for the payment of claims and operating expenses, maintaining adequate statutory capital and surplus levels, and meeting debt service requirements. Current and expected patterns of claim frequency and severity may change from period to period but generally are expected to continue within historical ranges. The Company's primary sources of cash are written premiums, investment income and proceeds from the sale and maturity of its invested assets. The Company believes that, within each operating company, total invested assets will be sufficient to satisfy all policy liabilities and that cash inflows from investment earnings, future premium receipts and reinsurance collections will be adequate to fund the payment of claims and operating expenses as needed.

Cash flows at the Parent are derived from dividends, management fees, and tax-sharing payments, as described below, from the subsidiaries. The principal cash needs of the Parent are for the payment of operating expenses, the acquisition of capital assets and debt service requirements, as well as the repurchase of shares and payments of any dividends as may be authorized and approved by the Company's board of directors from time to time. At September 30, 2025, the Parent had approximately $4.7 million of unrestricted cash and investments.

The Parent's insurance subsidiaries reported statutory net income of $8.0 million for the nine month period ended September 30, 2025, compared to statutory net income of $2.0 million for the nine month period ended September 30, 2024. Statutory results are impacted by the recognition of all costs of acquiring business. In periods in which the Company's first year premiums increase, statutory results are generally lower than results determined under GAAP. Statutory results for the Company's property and casualty operations may differ from the Company's results of operations under GAAP due to the deferral of acquisition costs for financial reporting purposes. The Company's life and health operations' statutory results may differ from GAAP results primarily due to the deferral of acquisition costs for financial reporting purposes, as well as the use of different reserving methods.

Over 90% of the invested assets of the Parent's insurance subsidiaries are invested in marketable securities that can be converted into cash, if required; however, the use of such assets by the Company is limited by state insurance regulations. Dividend payments to a parent corporation by its wholly owned insurance subsidiaries are subject to annual limitations and are restricted to 10% of statutory surplus or statutory earnings before recognizing realized investment gains of the individual insurance subsidiaries. At September 30, 2025, American Southern had $48.2 million of statutory capital and surplus and Bankers Fidelity had $34.6 million of statutory capital and surplus. In 2025, dividend payments by the Parent's insurance subsidiaries in excess of $6.3 million would require prior approval. Through September 30, 2025, the Parent received dividends of $6.3 million from its subsidiaries.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

The Parent provides certain administrative and other services to each of its insurance subsidiaries. The amounts charged to and paid by the subsidiaries include reimbursements for various shared services and other expenses incurred directly on behalf of the subsidiaries by the Parent. In addition, there is in place a formal tax-sharing agreement between the Parent and its insurance subsidiaries. As a result of the Parent's tax loss, it is anticipated that the tax-sharing agreement will continue to provide the Parent with additional funds from profitable subsidiaries to assist in meeting its cash flow obligations.

The Company has two statutory trusts which exist for the exclusive purpose of issuing trust preferred securities representing undivided beneficial interests in the assets of the trusts and investing the gross proceeds of the trust preferred securities in Junior Subordinated Debentures. The outstanding $18.0 million and $15.7 million of Junior Subordinated Debentures mature on December 4, 2032 and May 15, 2033, respectively, are callable quarterly, in whole or in part, only at the option of the Company, and have an interest rate of 3-month CME Term SOFR plus applicable tenor spread of 0.26161% plus an applicable margin. The margin ranges from 4.00% to 4.10%. At September 30, 2025, the effective interest rate was 8.51%. The obligations of the Company with respect to the issuances of the trust preferred securities represent a full and unconditional guarantee by the Parent of each trust's obligations with respect to the trust preferred securities. Subject to certain exceptions and limitations, the Company may elect from time to time to defer Junior Subordinated Debenture interest payments, which would result in a deferral of distribution payments on the related trust preferred securities. As of September 30, 2025, the Company has not made such an election.

The Company intends to pay its obligations under the Junior Subordinated Debentures using existing cash balances, dividend and tax-sharing payments from the operating subsidiaries, or from existing or potential future financing arrangements.

At September 30, 2025, the Company had 55,000 shares of Series D preferred stock ("Series D Preferred Stock") outstanding. All of the shares of Series D Preferred Stock are held by an affiliate of the Company's controlling shareholder. The outstanding shares of Series D Preferred Stock have a stated value of $100 per share; accrue annual dividends at a rate of $7.25 per share (payable in cash or shares of the Company's common stock at the option of the board of directors of the Company) and are cumulative. In certain circumstances, the shares of the Series D Preferred Stock may be convertible into an aggregate of approximately 1,378,000 shares of the Company's common stock, subject to certain adjustments and provided that such adjustments do not result in the Company issuing more than approximately 2,703,000 shares of common stock without obtaining prior shareholder approval; and are redeemable solely at the Company's option. The Series D Preferred Stock is not currently convertible. At September 30, 2025, the Company had accrued but unpaid dividends on the Series D Preferred Stock totaling $0.3 million.

Bankers Fidelity Life Insurance Company (''BFLIC") is a member of the Federal Home Loan Bank of Atlanta ("FHLB"), for the primary purpose of enhancing financial flexibility. As a member, BFLIC can obtain access to low-cost funding and also receive dividends on FHLB stock. The membership arrangement provides for credit availability of five percent of statutory admitted assets, or approximately $9.0 million, as of September 30, 2025. Additional FHLB stock purchases may be required based upon the amount of funds borrowed from the FHLB. As of September 30, 2025, BFLIC has pledged bonds having an amortized cost of $9.0 million to the FHLB. BFLIC may be required to post additional acceptable forms of collateral for any borrowings that it makes in the future from the FHLB. As of September 30, 2025, BFLIC does not have any outstanding borrowings from the FHLB.

On May 12, 2021, the Company entered into a Revolving Credit Agreement with Truist Bank as the lender (the "Lender"). The Revolving Credit Agreement provides for an unsecured $10.0 million revolving credit facility that originally matured on April 12, 2024. On March 22, 2024, the Company entered into a First Amendment (the "Amendment") to its Revolving Credit Agreement (as amended, the "Credit Agreement") with the Lender. The Amendment, among other things, (a) updates the interest rate provisions to memorialize that the Company pays interest on the unpaid principal balance of outstanding revolving loans at the Adjusted Term SOFR rate (as defined in the Credit Agreement), plus 2.00%, (b) extends the maturity date of the revolving credit facility to March 22, 2027, (c) requires the monthly payment of an unused commitment fee of 0.2% of the unused facility amount, and (d) requires that the Company maintain a consolidated net worth of not less than $64.2 million. Except as modified by the Amendment, the existing terms of the original Credit Agreement remain in effect.

The Credit Agreement requires the Company to comply with certain covenants, including a debt to capital ratio that restricts the Company from incurring consolidated indebtedness that exceeds 35% of the Company's consolidated capitalization at any time and maintaining a minimum consolidated net worth, as previously mentioned. The Credit Agreement also contains customary representations and warranties and events of default. Events of default include, among others, (a) the failure by the Company to pay any amounts owed under the Credit Agreement when due, (b) the failure to perform and not timely remedy certain covenants, (c) a change in control of the Company and (d) the occurrence of bankruptcy or insolvency events. Upon an event of default, the Lender may, among other things, declare all obligations under the Credit Agreement immediately due and payable and terminate the revolving commitments. As of September 30, 2025 and December 31, 2024, the Company had outstanding borrowings, including accrued interest of $4.0 million in each of the respective periods, under the Credit Agreement.

Cash and cash equivalents decreased from $35.6 million at December 31, 2024 to $34.4 million at September 30, 2025. The decrease in cash and cash equivalents during the nine month period ended September 30, 2025 was primarily attributable to net cash used in investing activities of $15.9 million primarily as a result of investment purchases exceeding investment sales and maturity of securities. Partially offsetting the decrease in cash and cash equivalents was net cash provided by operating activities of $15.2 million.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

The Company believes that existing cash balances as well as the dividends, fees, and tax-sharing payments it expects to receive from its subsidiaries and, if needed, borrowings under its credit facilities or additional borrowings from financial institutions will enable the Company to meet its liquidity requirements for the foreseeable future. Management is not aware of any current recommendations by regulatory authorities, which, if implemented, would have a material adverse effect on the Company's liquidity, capital resources or operations.

<u>Item 4. Controls and Procedures</u>

*Evaluation of Disclosure Controls and Procedures*

We maintain disclosure controls and procedures that are designed to ensure that information required to be disclosed in our Securities Exchange Act of 1934 (the "Exchange Act") reports is recorded, processed, summarized and reported within the time periods specified in the Securities and Exchange Commission's rules and forms, and that such information is accumulated and communicated to management, including the Chief Executive Officer and Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, an evaluation was performed under the supervision and with the participation of our management, including the Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company's disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) of the Securities Exchange Act of 1934). Based on that evaluation, management, including the Chief Executive Officer and Chief Financial Officer, concluded that disclosure controls and procedures were effective as of the end of the period covered by this report.

*Remediation of Material Weakness in Internal Control Over Financial Reporting*

Management of the Company is responsible for establishing and maintaining adequate internal control over financial reporting for the Company. The Company's internal control over financial reporting system has been designed to provide reasonable assurance regarding the reliability and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Management recognizes that there are inherent limitations in the effectiveness of any internal control system. Because of its inherent limitations, internal control over financial reporting may not prevent or detect all misstatements. Furthermore, the application of any evaluations of effectiveness on future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. Therefore, even those systems determined to be effective can provide only reasonable assurance with respect to financial statement preparation and presentation.

As initially disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2023, we have previously identified certain deficiencies in internal control that we believe rise to the level of a material weakness. A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis. Specifically, management determined that the design of the controls surrounding the process of reviewing insurance reserves and deferred acquisition costs within the Company's life and health segment was not effective. This deficiency in design did not enable the timely detection of anomalies in these values at the level of precision necessary to detect misstated values that may be material.

Notwithstanding these deficiencies, management believes that, because of the actions taken by management in identifying, and the efforts that the Company has been taking to address and correct, these deficiencies prior to the completion and filing of relevant periodic reports, and the effective operation of other internal controls over financial reporting, the material weakness did not result in any identified material misstatements to our financial statements. Similarly, there were no changes to any of our historical financial statements.

The Company's remediation efforts of the previously identified material weakness, which began in the quarter ended March 31, 2024, were concluded during the quarter ended September 30, 2025. During the quarter ended September 30, 2025, management conducted a systematic review of the components of underwriting income for the Company's Life and Medicare Supplement products. This review included independent calculations of actuarial values for these products using a comprehensive process that had been developed, tested, and implemented for each product over the period from October 1, 2024, through September 30, 2025. Based on this review, management did not identify any material misstatement in the Company's financial statements.

In furtherance of the remediation efforts, the Company has completed the development of product-specific systems to perform calculations independently of the actuarial models. These systems serve to verify that the product parameters and actuarial assumptions are properly reflected in the reported values. With the successful deployment of each of these systems during the quarter ended September 30, 2025, management believes that there are no material weaknesses over financial reporting.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

*Changes in Internal Control Over Financial Reporting*

Other than the remediation efforts described above, there were no changes in the Company's internal control over financial reporting during the quarter ended September 30, 2025 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.

*Inherent Limitations on Effectiveness of Controls*

No system of controls, no matter how well designed and implemented, can provide absolute assurance that the objectives of the system of controls are met. Furthermore, no evaluation of controls can provide absolute assurance that all control issues and any instances of fraud within a company have been detected.

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

#### PART II. OTHER INFORMATION
<u>Item 2. Unregistered Sales of Equity Securities and Use of Proceeds</u>

On October 31, 2016, the Board of Directors of the Company approved a plan that allows for the repurchase of up to 750,000 shares of the Company's common stock (the "Repurchase Plan") on the open market or in privately negotiated transactions, as determined by an authorized officer of the Company. Any such repurchases can be made from time to time in accordance with applicable securities laws and other requirements.

During the three month period ending September 30, 2025 no purchases of common stock of the Company were made by or on behalf of the Company pursuant to the Repurchase Plan. The maximum number of shares that may yet be purchased under the Repurchase Plan was 325,129 as of September 30, 2025.

The table below sets forth information regarding repurchases by the Company of shares of its common stock on a monthly basis during the three month period ending September 30, 2025.

---

| | | | | |
|:---|:---|:---|:---|:---|
|  Period | Total Number<br> of Shares<br> Purchased | Average<br> Price Paid<br> per Share | Total Number of<br> Shares Purchased<br> as Part of Publicly<br> Announced Plans<br> or Programs | Maximum Number<br> of Shares that may<br> Yet be Purchased<br> Under the Plans<br> or Programs |
|  July 1 – July 31, 2025 |  | $— |  | 325129 |
|  August 1 – August 31, 2025 |  |  |  | 325129 |
|  September 1 – September 30, 2025 |  |  |  | 325129 |
| &nbsp;&nbsp;&nbsp; **Total** |  | $— |  |  |

---

<u>Item 5. Other Information</u>

None of the Company's directors or officers adopted or terminated a Rule 10b5-1 trading arrangement or a non-Rule 10b5-1 trading arrangement during the quarter ended September 30, 2025, as such terms are defined under Item 408(a) of Regulation S-K.

<u>Item 6. Exhibits</u>

---

| | |
|:---|:---|
| [31.1](ef20054956_ex31-1.htm) | Certification of the Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| [31.2](ef20054956_ex31-2.htm) | Certification of the Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| [32.1](ef20054956_ex32-1.htm) | Certifications pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 101. INS | Inline XBRL Instance Document (the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document). |
| 101. SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101. CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101). |

---

------

*[**Table of Contents**](#TABLEOFCONTENTS)*

<u>SIGNATURES</u>

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

---

| | | |
|:---|:---|:---|
|  | ATLANTIC AMERICAN CORPORATION | ATLANTIC AMERICAN CORPORATION |
|  | (Registrant) | (Registrant) |
| Date: November 14, 2025 | By: | /s/ J. Ross Franklin |
|  |  | J. Ross Franklin |
|  |  | Vice President and Chief Financial Officer |
|  |  | (Principal Financial and Accounting Officer) |

---

------

## Exhibit 31.1

------

#### EXHIBIT 31.1

CERTIFICATION OF THE PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Hilton H. Howell, Jr., certify that:

<br> 1. I have reviewed this report on Form 10-Q of Atlantic American Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

<br> a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

<br> b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: <u>November 14, 2025</u> | /s/ Hilton H. Howell, Jr. |
|  | Hilton H. Howell, Jr. |
|  | President and Chief Executive Officer |

---

------

## Exhibit 31.2

------

#### EXHIBIT 31.2

CERTIFICATION OF THE PRINCIPAL FINANCIAL OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, J. Ross Franklin, certify that:

<br> 1. I have reviewed this report on Form 10-Q of Atlantic American Corporation;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant's other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5. The registrant's other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of registrant's board of directors (or persons performing the equivalent functions):

<br> a) all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

<br> b) any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

---

| | |
|:---|:---|
| Date: <u>November 14, 2025</u> | /s/ J. Ross Franklin |
|  | J. Ross Franklin |
|  | Vice President and |
|  | Chief Financial Officer |

---

------

## Exhibit 32.1

------

#### EXHIBIT 32.1

Certifications Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

Pursuant to 18 U.S.C. §1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, in connection with the filing of the Quarterly Report on Form 10-Q of Atlantic American Corporation (the "Company") for the quarterly period ended September 30, 2025, as filed with the Securities and Exchange Commission on the date hereof (the "Report"), each of the undersigned officers of the Company certifies, that, to such officer's knowledge:

<br> (1) The Report fully complies with the requirements of Section 13 (a) or 15 (d) of the Securities Exchange Act of 1934; and

<br> (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company as of the dates and for the periods expressed in the Report.

---

| | |
|:---|:---|
| Date:<br> <u>November 14, 2025</u> | /s/ Hilton H. Howell, Jr. |
|  | Hilton H. Howell, Jr. |
|  | President and Chief Executive Officer |
| Date:<br> <u>November 14, 2025</u> | /s/ J. Ross Franklin |
|  | J. Ross Franklin |
|  | Vice President and |
|  | Chief Financial Officer |

---

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signature that appears in typed form within the electronic version of this written statement required by Section 906, has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

------